Cholangitis (primary sclerosing, PSC)

K11_CHOLANGI

sclerosing cholangitis: A chronic, autoimmune inflammatory liver disorder characterized by narrowing and scarring of the lumen of the bile ducts. It is often seen in patients with ulcerative colitis. Signs and symptoms include jaundice, fatigue, and malabsorption. It may lead to cirrhosis and liver failure.

Suggest a new description

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	557745
1. Apply sex-specific rule None	557745
2. Check conditions None	557745
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — K83.0 Hospital discharge: ICD-9 — 5761 Hospital discharge: ICD-8 — 5750[4-5] Cause of death: ICD-10 — K83.0 Cause of death: ICD-9 — 5761 Cause of death: ICD-8 — 5750[4-5] 2 out of 7 registries used, show all original rules.	2969
4. Check minimum number of events None	2969
5. Include endpoints None	2969
6. Filter based on genotype QC (FinnGen only)	2665

Control definitions (FinnGen only)

Control exclude: K11_GALLBILPANC

Extra metadata

Level in the ICD hierarchy: 3
First used in FinnGen datafreeze: DF2
Parent code in ICD-10: K83
Name in latin: Cholangitis

NAME	K11_CHOLANGI
CONTROL_EXCLUDE	K11_GALLBILPANC
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	K830
HD_ICD_9	5761
HD_ICD_8	5750[4-5]
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	K830
COD_ICD_9	5761
COD_ICD_8	5750[4-5]
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Cholangitis (primary sclerosing, PSC) based on the number of shared cases.

Similar with more cases:

Similar with less cases:

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	17623	8929	8513
Only index persons	14119	7308	6811
Unadjusted period prevalence (%)
Whole population	0.25	0.26	0.24
Only index persons	0.26	0.27	0.26
Median age at first event (years)
Whole population	69.88	71.11	68.55
Only index persons	69.40	70.72	67.98

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	2665	1279	1386
Unadjusted period prevalence (%)	0.55	0.45	0.64
Median age at first event (years)	64.82	61.56	67.83

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
2745: Matched controls
27450

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

L04AX01

ATC

azathioprine; systemic

10.0

315.7

386

442

R10.1

ICD-10 Finland

Pain localized to upper abdomen

5.0

311.8

881

2369

JN1BG

NOMESCO Finland

MRI examination of upper part of abodmen with high intensity magnet

38.6

307.7

204

K51.9

ICD-10 Finland

Ulcerative colitis, unspecified

13.7

307.7

390

328

JL5BG

NOMESCO Finland

MRI examinaiton of bile and pancreas ducts with high intesity magnet

100.7

307.7

648

K80.3

ICD-10 Finland

Calculus of bile duct with cholangitis

+∞

307.7

331

JL5CG

NOMESCO Finland

Extensive MRI examinaiton of bile and pancreas ducts with high intesity magnet

189.4

307.7

226

202

Kela drug reimbursment

Connective tissue diseases, rheumatoid arthritis and comparable disease

5.8

307.7

738

1634

JKA21

NOMESCO Finland

Laparoscopic cholecystectomy

449.7

307.7

652

K80.2

ICD-10 Finland

Calculus of gallbladder without cholecystitis

239.6

307.7

643

208

Kela drug reimbursment

Ulcerative colitis and Crohn's disease

13.6

307.7

551

496

K80.0

ICD-10 Finland

Calculus of gallbladder with acute cholecystitis

961.1

307.7

410

K80.5

ICD-10 Finland

Calculus of bile duct without cholangitis or cholecystitis

1533.2

307.7

502

UJK02

NOMESCO Finland

ERCP

526.3

307.7

1024

K83.0

ICD-10 Finland

Cholangitis

4503599627370496.0

307.7

2665

Z94.4

ICD-10 Finland

Liver transplant status

129.4

307.7

170

JKE12

NOMESCO Finland

Endoscopic extraction of calculus from bile duct

2302.8

307.7

417

A05AA02

ATC

ursodeoxycholic acid; oral

130.0

307.7

835

D37.7

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Other digestive organs

17.4

307.7

286

182

J01MA12

ATC

levofloxacin; systemic

5.1

307.7

1060

3035

JKE02

NOMESCO Finland

Transduodenal endoscopic incision of common bile duct orifice

510.2

307.7

567

JKE18

NOMESCO Finland

Endoscopic internal drainage of bile duct

298.5

307.7

407

K51.5

ICD-10 Finland

Left sided colitis

17.4

307.7

417

280

K83.1

ICD-10 Finland

Obstruction of bile duct

2573.1

307.7

640

JKA20

NOMESCO Finland

Cholecystectomy

49.2

307.7

226

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

15.8

307.7

1014

983

JN3AD

NOMESCO Finland

Abdominal CT examination

8.0

307.7

967

1742

JL5SB

NOMESCO Finland

Endoscopic retrograd cholangiopancreaticography

641.8

307.7

713

C25.0

ICD-10 Finland

Malignant neoplasm: Head of pancreas

42.3

307.7

247

JN1CG

NOMESCO Finland

Extensive MRI examination of upper part of abdomen with high intensity magnet

35.4

307.7

494

169

JL5AG

NOMESCO Finland

Simple MRI examinaiton of bile and pancreas ducts with high intesity magnet

90.4

307.7

262

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

7.0

307.7

951

1921

A07EC02

ATC

mesalazine; oral, rectal

10.5

307.7

553

645

JN1DG

NOMESCO Finland

Very extensive MRI examination of upper part of abdomen with high intensity magnet

41.4

307.7

443

127

JN3BD

NOMESCO Finland

Extensive abdominal CT

6.6

307.7

621

1158

JKE98

NOMESCO Finland

Other transduodenal endoscopic operation on bile duct or ampulla of Vater

1067.4

307.7

922

A09AA02

ATC

multienzymes (lipase, protease etc.); oral

38.8

307.7

323

JJ2AT

NOMESCO Finland

Biopsy of liver with ultrasound guidance

26.4

307.7

443

199

R17

ICD-10 Finland

Hyperbilirubinaemia, with or without jaundice, not elsewhere classified

38.7

307.7

307

JLC30

NOMESCO Finland

Pancreatoduodenectomy

105.7

291.3

150

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

4.1

289.8

1338

5152

133

Kela drug reimbursment

Severe chronic pancreatic insufficiency

+∞

283.3

267

A41.5

ICD-10 Finland

Sepsis due to other Gram-negative organisms

9.3

276.2

354

429

JKE22

NOMESCO Finland

Endoscopic extraction of foreign body from bile duct

2693.6

269.1

256

WX402

NOMESCO Finland

General anaesthesia

4.1

263.0

1029

3486

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

3.8

260.2

1406

5924

UJF30

NOMESCO Finland

Ileoscopy through colon

5.2

258.8

646

1547

R50.9

ICD-10 Finland

Fever, unspecified

4.2

236.4

814

2492

127

Kela drug reimbursment

Transplant complication

17.5

235.3

196

120

A07EA06

ATC

budesonide; oral, local oral

8.8

232.5

309

390

K51.8

ICD-10 Finland

Other ulcerative colitis

16.4

231.1

199

130

JN3DE

NOMESCO Finland

Abdominal extensive ultrasoudn examination with blood flow measurements after transplantation

46.1

230.6

136

JKE32

NOMESCO Finland

Endoscopic dilatation of bile duct

601.1

227.0

222

JJ1LE

NOMESCO Finland

Ultrasound elastography of liver

22.9

225.8

166

K51.1

ICD-10 Finland

Ulcerative (chronic) ileocolitis

22.7

223.9

165

JKE25

NOMESCO Finland

Endoscopic external drainage of bile duct

108.1

221.8

114

601

Kela drug reimbursment

Severe malabsorption of nutrients, mainly fats

24.4

219.4

157

K81.0

ICD-10 Finland

Acute cholecystitis

262.9

215.3

218

K83.9

ICD-10 Finland

Disease of biliary tract, unspecified

1117.6

214.5

207

K80.8

ICD-10 Finland

Other cholelithiasis

49.9

214.1

124

TPH04

NOMESCO Finland

Cathetrisation of vein

3.6

213.0

999

3745

A49.9

ICD-10 Finland

Bacterial infection, unspecified

4.3

206.3

656

1877

K85.9

ICD-10 Finland

Acute pancreatitis, unspecified

+∞

205.9

195

UJK12

NOMESCO Finland

Peroral cholangioscopy

1958.0

201.5

193

JN3CD

NOMESCO Finland

Abdominal CT examination both without and with contrast

9.1

200.3

255

304

J01MA02

ATC

ciprofloxacin; systemic

3.2

196.6

1510

7548

K74.3

ICD-10 Finland

Primary biliary cirrhosis

34.4

196.5

125

K76.9

ICD-10 Finland

Liver disease, unspecified

17.5

192.7

160

UJF32

NOMESCO Finland

Coloscopy

3.3

190.9

1101

4638

JK3BT

NOMESCO Finland

Catherisation of bile duct with X-ray guidance

384.0

181.8

181

WX302

NOMESCO Finland

Thoracal epidural anesthesy

6.1

181.5

342

627

C25.9

ICD-10 Finland

Malignant neoplasm: Pancreas, unspecified

18.9

180.7

144

K83.8

ICD-10 Finland

Other specified diseases of biliary tract

1922.9

179.1

172

JN4AD

NOMESCO Finland

Body CT examination

4.0

173.6

593

1770

L04AD02

ATC

tacrolimus; systemic

18.9

172.0

137

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

5.3

170.3

377

800

WX404

NOMESCO Finland

Intravenous generell anesthesy

3.4

169.0

833

3157

L04AA06

ATC

mycophenolic acid; systemic

11.1

162.2

176

168

D37.6

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Liver, gallbladder and bile ducts

13.4

159.9

153

120

JJ1CE

NOMESCO Finland

Liver, bile duct and pancreas endoscopic ultrasound examination

64.9

159.7

130

Kela drug reimbursment

Malignant tumour

4.1

159.3

500

1399

K50.8

ICD-10 Finland

Other Crohn disease

13.5

159.0

152

119

K80.1

ICD-10 Finland

Calculus of gallbladder with other cholecystitis

1636.4

156.8

151

N02AA05

ATC

oxycodone; systemic

3.1

152.5

849

3431

C22.1

ICD-10 Finland

Malignant neoplasm: Intrahepatic bile duct carcinoma

39.2

148.5

L04AD01

ATC

ciclosporin; systemic

11.6

148.3

156

142

K51.0

ICD-10 Finland

Ulcerative (chronic) pancolitis

19.5

145.3

114

TJJ00

NOMESCO Finland

Percutaneous needle biopsy of liver

42.8

145.1

JA3AT

NOMESCO Finland

Cathetrisation of abdominal cavity with ultrasound guidance

10.8

139.8

154

150

K73.2

ICD-10 Finland

Chronic active hepatitis, not elsewhere classified

51.5

139.0

WX004

NOMESCO Finland

Patient-controlled sedation

48.4

137.3

GD1AA

NOMESCO Finland

Thorax X-ray examination

2.7

136.1

1660

9940

JJC00

NOMESCO Finland

Allogenic transplantation of liver

185.7

135.9

141

K50.1

ICD-10 Finland

Crohn disease of large intestine

14.7

133.6

121

R74.0

ICD-10 Finland

Elevation of levels of transaminase and lactic acid dehydrogenase [LDH]

9.4

133.1

162

181

K85

ICD-10 Finland

Acute pancreatitis

204.3

131.9

136

K75.9

ICD-10 Finland

Inflammatory liver disease, unspecified

15.8

131.3

114

JK3NB

NOMESCO Finland

Percutaneous transhepatic cholangiography

444.7

129.0

128

K85.8

ICD-10 Finland

Other acute pancreatitis

+∞

128.1

122

A41.8

ICD-10 Finland

Other specified sepsis

8.6

127.0

166

203

UJF14

NOMESCO Finland

Enteroscopy of ileoanal anastomosis

27.7

126.5

Z51.5

ICD-10 Finland

Palliative care

3.6

125.9

473

1485

I85.9

ICD-10 Finland

Oesophageal varices without bleeding

17.4

125.9

104

XJD02

NOMESCO Finland

Peroral endoscopic ultrasonography

21.4

123.7

P01AB01

ATC

metronidazole; oral, rectal

2.6

123.0

1270

6915

K50.9

ICD-10 Finland

Crohn disease, unspecified

11.0

120.3

130

123

D98

ICPC

Cholecystitis/cholelithiasis

47.9

119.8

C24.9

ICD-10 Finland

Malignant neoplasm: Biliary tract, unspecified

49.8

117.3

WX002

NOMESCO Finland

Sedation and analgesia

2.8

114.7

750

3244

JJ9AE

NOMESCO Finland

Ultrasound examination of liver transplant

301.7

114.0

115

JN4CD

NOMESCO Finland

Very extensive body CT

5.6

113.8

226

431

WD125

NOMESCO Finland

Demanding cystostatic therapy of methastized malignancy

5.1

112.0

252

537

WVA20

NOMESCO Finland

Medicine administration

6.6

111.5

185

296

K86.1

ICD-10 Finland

Other chronic pancreatitis

1122.7

111.3

108

TPH07

NOMESCO Finland

Cathetrisation of artery

3.3

110.6

499

1750

K80.4

ICD-10 Finland

Calculus of bile duct with cholecystitis

1101.0

109.2

106

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

2.8

107.5

707

3054

K81.9

ICD-10 Finland

Cholecystitis, unspecified

+∞

107.0

102

K85.1

ICD-10 Finland

Biliary acute pancreatitis

+∞

105.9

101

WX408

NOMESCO Finland

General anesthesy, balanced

2.6

104.5

877

4264

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

5.1

104.5

231

484

JDW98

NOMESCO Finland

Other transluminal endoscopic operation on stomach or duodenum

10.3

103.4

117

118

E13.9

ICD-10 Finland

Other specified diabetes mellitus, without complications

15.2

101.8

A41.9

ICD-10 Finland

Sepsis, unspecified

5.2

100.0

218

451

C10AC01

ATC

colestyramine; oral

7.0

98.1

154

232

A02BC02

ATC

pantoprazole; systemic

2.5

95.8

2034

14637

N02AX02

ATC

tramadol; systemic, rectal

2.3

93.4

1346

8197

UJF12

NOMESCO Finland

Enteroscopy through intestinal stoma

33.5

92.1

WZC20

NOMESCO Finland

Multidisciplinary treatment meeting

4.1

92.0

272

717

A03FA01

ATC

metoclopramide; systemic, rectal

2.5

91.9

761

3645

JAH00

NOMESCO Finland

Laparotomy

6.0

90.6

165

289

JK3NT

NOMESCO Finland

Percutaneous transhepatic dilatation of bileducts

907.5

90.3

K50.0

ICD-10 Finland

Crohn disease of small intestine

9.6

89.4

106

114

JK4ZT

NOMESCO Finland

Percutaneous transhepatic implantation of bile duct prothesis

160.4

88.7

ZXE00

NOMESCO Finland

One hour or less

2.2

88.6

1220

7249

L01BB02

ATC

mercaptopurine; oral

10.7

86.3

JK3FT

NOMESCO Finland

Exchange of bile duct catheter with radiological guidance

301.3

86.2

K75.0

ICD-10 Finland

Abscess of liver

40.8

85.6

A04AA02

ATC

granisetron; systemic, transdermal

3.7

85.2

288

833

326

Kela drug reimbursment

Adalimumab, golimumab, infliximab and ustekinumab (intestinal diseases)

11.2

82.7

NK6QA

NOMESCO Finland

Measurement of bone density from two or more locations with X-ray

3.6

78.7

287

872

L01BC06

ATC

capecitabine; oral

4.5

77.9

198

464

R4190

NOMESCO Finland

Nutritional therapy

4.4

77.6

205

495

5562A

ICD-9 Finland

Idiopathic proctocolitis, Ulcerative (chronic) proctitis

27.0

77.3

K74.6

ICD-10 Finland

Other and unspecified cirrhosis of liver

8.0

75.9

104

134

JAH01

NOMESCO Finland

Laparoscopy

4.9

75.6

173

372

ZXD05

NOMESCO Finland

Urgent procedure

2.2

75.0

945

5336

K85.0

ICD-10 Finland

Idiopathic acute pancreatitis

748.2

74.6

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

2.4

74.0

609

2874

WX602

NOMESCO Finland

Repeated or continuing anesthesia shots throug a catheter

3.2

71.7

321

1106

K56.6

ICD-10 Finland

Other and unspecified intestinal obstruction

5.0

71.1

159

335

JKD20

NOMESCO Finland

Anastomosis of bile duct to jejunum

361.4

71.0

K90.3

ICD-10 Finland

Pancreatic steatorrhoea

29.9

70.8

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

2.1

70.5

1082

6553

56310

ICD-8 Finland

Chronic enteritis and ulcerative colitis, Ulcerative colitis

22.6

69.5

K51.3

ICD-10 Finland

Ulcerative (chronic) rectosigmoiditis

6.5

68.6

114

182

8140/3-C25.9

ICD-O-3

Adenocarcinoma, NOS, of pancreas, NOS

15.3

68.3

ZX120

NOMESCO Finland

Intravenous

2.9

67.9

364

1386

JF1AB

NOMESCO Finland

Passage examination of small bowell with X-ray

7.2

67.9

102

146

C78.7

ICD-10 Finland

Secondary malignant neoplasm of liver and intrahepatic bile duct

5.3

67.1

139

274

K73.9

ICD-10 Finland

Chronic hepatitis, unspecified

25.2

66.8

JA2AT

NOMESCO Finland

Abdominal puncture with ultrasound guidance

10.7

66.7

JK3SB

NOMESCO Finland

Endoscopic retrorade cholangiography

232.3

66.5

H02AB06

ATC

prednisolone; systemic

2.0

65.0

1407

9540

I81

ICD-10 Finland

Portal vein thrombosis

16.9

63.5

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

2.6

63.0

431

1855

K51

ICD-10 Finland

Ulcerative colitis

9.0

62.8

L04AA01

ATC

[U] ciclosporin

8.3

62.5

103

8000/3-C25.9

ICD-O-3

Neoplasm, malignant of pancreas, NOS

14.2

62.2

D76

ICPC

Malignant neoplasm pancreas

24.8

62.2

A10AB05

ATC

insulin aspart; parenteral

3.0

61.7

306

1114

A07AA11

ATC

rifaximin; oral

25.7

61.5

R11

ICD-10 Finland

Nausea and vomiting

2.9

61.4

323

1215

JCA22

NOMESCO Finland

Endoscopic ligature of oesophageal varices

21.8

60.5

JJ5AT, ,

NOMESCO Finland

211.3

60.3

JFH30

NOMESCO Finland

Total colectomy, mucosal proctectomy and ileoanal anastomosis without ileostomy

27.7

60.3

WZC00

NOMESCO Finland

Treatment plan or consultation

2.0

59.7

1086

6883

WX419

NOMESCO Finland

Other general anesthesy

9.9

59.1

K86.00

ICD-10 Finland

Acute pancreatitis caused by alcohol

590.5

58.9

TK800

NOMESCO Finland

Hemodialysis

5.6

58.7

113

208

J01DB01

ATC

cefalexin; oral

2.3

58.7

2268

18541

L04AC05

ATC

ustekinumab; parenteral

17.7

57.6

JN1CD

NOMESCO Finland

Very extensive CT examination of upper part of abdomen

13.0

57.2

D13.6

ICD-10 Finland

Benign neoplasm: Pancreas

14.3

57.1

C03CA01

ATC

furosemide; systemic

1.9

56.9

1042

6592

B01AB05

ATC

enoxaparin; parenteral

1.9

54.9

929

5710

D37.9

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Digestive organ, unspecified

15.9

54.7

TPH20

NOMESCO Finland

Insertion of central venous catheter through subclavian or brachiocephalic vein

4.7

54.4

129

285

UJF02

NOMESCO Finland

Peroral enteroscopy

12.5

53.9

ZXD10

NOMESCO Finland

Scheduled procedure

1.9

53.5

1095

7148

57505

ICD-8 Finland

Cholecystitis and cholangitis, without mention of calculus, Cholangitis alia sive NUD

+∞

53.3

O99.6

ICD-10 Finland

Diseases of the digestive system complicating pregnancy, childbirth and the puerperium

17.2

53.2

C22.0

ICD-10 Finland

Malignant neoplasm: Liver cell carcinoma

9.7

53.1

K86.3

ICD-10 Finland

Pseudocyst of pancreas

527.9

52.7

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.8

52.4

1440

10287

JF1CG

NOMESCO Finland

Extensive MRI of small bowel

12.3

52.3

TPX10

NOMESCO Finland

Implantation of vascular injection port

4.4

51.7

135

322

JN4BD

NOMESCO Finland

Extensive body CT

2.5

51.5

366

1595

K72.0

ICD-10 Finland

Acute and subacute hepatic failure

16.8

51.4

R94.5

ICD-10 Finland

Abnormal results of liver function studies

7.0

50.9

114

T81.8

ICD-10 Finland

Other complications of procedures, not elsewhere classified

5.6

50.6

178

A07EA02

ATC

hydrocortisone; rectal

4.9

50.5

112

234

K86.08

ICD-10 Finland

Alcohol-induced chronic pancreatitis

+∞

50.2

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

2.0

50.1

649

3614

WD105

NOMESCO Finland

Cystostatic therapy of methastized malignancy

3.7

49.9

166

472

K92.1

ICD-10 Finland

Melaena

3.0

49.8

230

802

TJK01

NOMESCO Finland

Laparoscopic cholangiography

496.7

49.5

5761C

ICD-9 Finland

Other disorders of biliary tract, Cholangitis[CHOLANGITIS SCLEROSIVA]

+∞

49.1

R18

ICD-10 Finland

Ascites

5.1

49.0

105

213

WX610

NOMESCO Finland

Patient controlled analgesia

13.8

48.5

N02AB03

ATC

fentanyl; nasal, sublingual, transdermal

3.3

48.2

196

634

UJF92

NOMESCO Finland

Capsular endoscopy

5.0

48.2

106

220

A07AA09

ATC

vancomycin; oral

6.4

48.0

128

B01AB10

ATC

tinzaparin; parenteral

2.4

47.8

362

1621

K52.9

ICD-10 Finland

Noninfective gastroenteritis and colitis, unspecified

3.7

47.5

155

435

ZXE30

NOMESCO Finland

More than five and less than seven hours

3.3

47.3

187

594

ZXE40

NOMESCO Finland

More than seven and less than nine hours

4.8

47.3

110

239

JN1BD

NOMESCO Finland

Extensive CT examination of upper part of abdomen

11.9

47.2

H02AB02

ATC

dexamethasone; systemic

2.4

47.1

382

1763

SPAT1255

SPAT

Intravenous administration of medicine

2.9

47.0

244

907

K86.2

ICD-10 Finland

Cyst of pancreas

166.2

47.0

JJA20

NOMESCO Finland

Open biopsy of liver

16.2

47.0

WX000

NOMESCO Finland

Monitoring vital functions without anesthesy

3.5

46.3

167

501

A10AE04

ATC

insulin glargine; parenteral

2.5

46.0

328

1428

K86.9

ICD-10 Finland

Disease of pancreas, unspecified

101.9

45.9

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

2.3

45.7

411

1981

ZXE20

NOMESCO Finland

More than three and less than five hours

2.2

45.7

434

2140

H02AB04

ATC

methylprednisolone; systemic

2.2

45.2

440

2191

D02

ICPC

Abdominal pain epigastric

3.1

45.0

199

676

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

2.1

44.4

505

2669

A06AH03

ATC

naloxegol; oral

5.7

44.3

149

WW500

NOMESCO Finland

Blood transfusion

3.4

44.1

165

506

R93.2

ICD-10 Finland

Abnormal findings on diagnostic imaging of liver and biliary tract

8.9

44.1

A04AA01

ATC

ondansetron; systemic, rectal

2.6

43.6

280

1159

UJF45

NOMESCO Finland

Flexible sigmoidoscopy with biopsy

2.6

43.1

282

1178

A02BC05

ATC

esomeprazole; systemic

1.8

42.7

1071

7304

I85.0

ICD-10 Finland

Oesophageal varices with bleeding

16.6

42.7

H02AB07

ATC

prednisone; oral

2.2

42.5

427

2149

WZC30

NOMESCO Finland

Teaching

2.1

41.7

499

2682

D97

ICPC

Liver disease NOS

13.6

41.7

K43.9

ICD-10 Finland

Other and unspecified ventral hernia without obstruction or gangrene

3.4

41.5

152

460

K72.9

ICD-10 Finland

Hepatic failure, unspecified

10.4

41.4

R10.0

ICD-10 Finland

Acute abdomen

4.1

40.9

115

290

K86.8

ICD-10 Finland

Other specified diseases of pancreas

111.8

40.8

N17.9

ICD-10 Finland

Acute renal failure, unspecified

3.1

40.7

173

574

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

2.3

40.3

328

1512

TPH30

NOMESCO Finland

Insertion of central venous catheter through periferal vein

5.1

40.2

174

JLB28

NOMESCO Finland

Endoscopic internal drainage of pancreatic duct

403.3

40.2

Z2221

NOMESCO Finland

Medical doctor

1.8

40.2

774

4867

WX892

NOMESCO Finland

Monitored bed care

2.5

39.9

271

1151

JLW98

NOMESCO Finland

Other transluminal endoscopic operation on pancreas

142.1

39.8

5742A

ICD-9 Finland

Cholelithiasis, Calculus of gallbladder without mention of cholecystitis[CHOLECYSTOLITHIASIS SINE CHOLECYSTITIDE,SINE OBSTR]

+∞

39.7

Z94.0

ICD-10 Finland

Kidney transplant status

6.9

39.5

H02AB09

ATC

hydrocortisone; systemic

4.2

39.5

108

267

A06AD11

ATC

lactulose; oral

2.0

39.3

498

2728

K56.5

ICD-10 Finland

Intestinal adhesions [bands] with obstruction

5.2

38.8

157

C79.8

ICD-10 Finland

Secondary malignant neoplasm of other specified sites

3.4

38.7

147

455

K83.3

ICD-10 Finland

Fistula of bile duct

+∞

38.6

PG1DE

NOMESCO Finland

Other extensive ultrasound examination of artery

3.0

38.5

174

598

B99

ICD-10 Finland

Other and unspecified infectious diseases

4.8

38.2

182

6663

FHL

Cholecystectomy and cholangiography

197.7

37.9

SPAT1262

SPAT

Handing over of treatment supplies

2.0

37.6

516

2900

C03DA01

ATC

spironolactone; oral

2.1

36.6

412

2157

WX882

NOMESCO Finland

High dependency care

3.6

35.9

124

361

J01EE01

ATC

sulfamethoxazole and trimethoprim; systemic

2.8

35.9

194

735

J18.9

ICD-10 Finland

Pneumonia, unspecified

1.7

35.6

820

5399

D94

ICPC

Chronic enteritis/ulcerative colitis

8.8

34.9

C24.00

ICD-10 Finland

Hepatic duct

125.0

34.8

JKB20

NOMESCO Finland

Intraoperative cholangioscopy

+∞

34.4

TJK00

NOMESCO Finland

Intraoperative cholangiography

177.2

33.8

IAZ97

NOMESCO Finland

Psychiatric consultation in another specialty

5.0

33.1

148

JKB00

NOMESCO Finland

Incision of bile duct

331.0

33.0

C24.0

ICD-10 Finland

Malignant neoplasm: Extrahepatic bile duct

118.2

32.7

WB121

NOMESCO Finland

Demanding neoadjuvant cytostatic therapy

6.2

32.7

A04.7

ICD-10 Finland

Enterocolitis due to Clostridium difficile

3.6

32.2

107

304

C23

ICD-10 Finland

Malignant neoplasm of gallbladder

62.5

32.1

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

2.0

32.1

421

2321

3AC01, ,

NOMESCO Finland

6.1

32.0

ZXE10

NOMESCO Finland

More than one and less than three hours

1.6

31.4

944

6623

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

2.1

31.4

342

1764

JKE15

NOMESCO Finland

Endoscopic lithotripsy in bile duct

+∞

31.3

K81.1

ICD-10 Finland

Chronic cholecystitis

+∞

31.3

K75.4

ICD-10 Finland

Autoimmune hepatitis

32.0

31.3

JFG00

NOMESCO Finland

Closure of loop enterostomy without resection

8.0

31.1

JFA15

NOMESCO Finland

Endoscopic polypectomy in colon

2.5

31.0

204

852

XX2RW, ,

NOMESCO Finland

5.1

30.8

130

UJD02

NOMESCO Finland

Gastroscopy

2.8

30.8

165

622

WX704

NOMESCO Finland

Intubation

2.4

30.8

229

1011

K80

ICD-10 Finland

Cholelithiasis

9.8

30.3

JK3MB

NOMESCO Finland

Postoperative cholangiography

+∞

30.3

B01AB04

ATC

dalteparin; parenteral

2.7

30.0

167

642

KA1MN

NOMESCO Finland

Glomerular filtration rate (GFR) Isotope mesurement

12.1

29.9

A02BC01

ATC

omeprazole; systemic

1.7

29.8

721

4770

K52.88

ICD-10 Finland

Other specified noninfective gastroenteritis and colitis

3.8

29.7

240

L04AB04

ATC

adalimumab; parenteral

4.2

29.6

196

8170/3-C22.0

ICD-O-3

Hepatocellular carcinoma, NOS, of liver

8.7

29.3

JFA98

NOMESCO Finland

Other transluminal endoscopic local operation on intestine

4.0

29.2

211

JAD30

NOMESCO Finland

Repair of incisional hernia using prosthetic material

4.7

28.8

146

A07EA01

ATC

prednisolone; oral, rectal

9.1

28.6

8140/3-C25.0

ICD-O-3

Adenocarcinoma, NOS, of head of pancreas

49.1

28.4

XX4AT

NOMESCO Finland

Other canalization with ultrasound guidance

10.1

28.3

57409

ICD-8 Finland

Cholelithiasis, Unspecified

+∞

28.2

UJK52

NOMESCO Finland

Endoscopy of biliary tract in connection with endoscopic retrograde cholangiopancreatography

+∞

28.2

6662

FHL

Cholecystectomy

64.7

28.0

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.4

27.8

204

894

1370

FHL

Colonoscopy, whole colon

8.1

27.8

JJ3AT

NOMESCO Finland

Cytology of liver with ultrasound guidance

43.0

27.7

R4110

NOMESCO Finland

Physiotherapy

1.6

27.3

760

5195

JN1AD

NOMESCO Finland

CT examination of upper part of abdomen

8.0

27.3

C25.1

ICD-10 Finland

Malignant neoplasm: Body of pancreas

8.8

27.2

C22.9

ICD-10 Finland

Malignant neoplasm: Liver, unspecified

8.4

27.0

D64.9

ICD-10 Finland

Anaemia, unspecified

1.9

26.9

356

1961

Z93.2

ICD-10 Finland

Ileostomy status

10.8

26.9

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

1.8

26.9

514

3175

K83

ICD-10 Finland

Other diseases of biliary tract

75.9

26.8

C24.02

ICD-10 Finland

Common bile duct

273.7

26.8

ZXE50

NOMESCO Finland

More than nine and less than 12 hours

4.5

26.7

151

1280

FHL

Endoscopic retrograde cholangiography and pancreaticography

141.4

26.7

E14.9

ICD-10 Finland

Unspecified diabetes mellitus, without complications

4.2

26.5

173

A03

ICPC

Fever

1.8

26.4

438

2592

C78.6

ICD-10 Finland

Secondary malignant neoplasm of retroperitoneum and peritoneum

5.2

25.7

104

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

1.8

25.7

417

2451

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

2.9

25.5

126

455

WX872

NOMESCO Finland

Intensive care

2.5

25.2

163

674

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

2.1

25.2

253

1261

253, ,

Kela drug reimbursment

22.8

25.2

3042, ,

Kela drug reimbursment

22.8

25.2

5761X

ICD-9 Finland

Other disorders of biliary tract, Cholangitis[CHOLANGITIS ALIA]

+∞

25.0

SPAT1148

SPAT

Treatment of chronic ulcer or burn

1.8

24.6

380

2197

ZJX00

NOMESCO Finland

Double balloon technique in gastroenterological endoscopy

48.8

24.3

K92.0

ICD-10 Finland

Haematemesis

3.3

24.2

295

JFB00

NOMESCO Finland

Partial resection of small intestine

4.3

24.0

147

B03BA03

ATC

hydroxocobalamin; parenteral

2.3

23.9

181

804

215

Kela drug reimbursment

Diabetes, non-insulin-treated

1.6

23.9

636

4277

JN3CG

NOMESCO Finland

Extensive MRI examination of abdomen with high intensity magnet

8.1

23.9

Z2446

NOMESCO Finland

Social worker

2.2

23.7

203

950

TBW99

NOMESCO Finland

Other minor procedure in endocrine surgery

8.7

23.7

Y83.9

ICD-10 Finland

Surgical procedure, unspecified as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

3.1

23.6

100

331

R53

ICD-10 Finland

Malaise and fatigue

1.6

23.6

675

4620

Z01.8

ICD-10 Finland

Other specified special examinations

1.6

23.5

599

3981

D01

ICPC

Abdominal pain/cramps general

1.9

23.3

309

1699

SPAT1263

SPAT

Sampling

1.5

23.3

1036

7827

JN1CM

NOMESCO Finland

Upper part of abdomen extensive MRI examination with 3 Tesla magnet

22.3

23.0

57401

ICD-8 Finland

Cholelithiasis, Cum cholecystitide chronica

+∞

22.9

L03AA02

ATC

filgrastim; parenteral

3.0

22.9

100

337

A07EC01

ATC

sulfasalazine; oral, rectal

2.1

22.7

219

1074

K56.7

ICD-10 Finland

Ileus, unspecified

3.8

22.7

180

ZX108

NOMESCO Finland

Inhalation

6.5

22.6

JDE00

NOMESCO Finland

Gastrojejunostomy

26.1

22.6

PHN73

NOMESCO Finland

Reconstruction of superior mesenteric or portal vein

121.0

22.6

A06AC01

ATC

ispaghula (psylla seeds); oral

1.6

22.2

674

4669

C24.1

ICD-10 Finland

Malignant neoplasm: Ampulla of Vater

52.5

22.1

K51.2

ICD-10 Finland

Ulcerative (chronic) proctitis

4.2

22.0

144

5561A

ICD-9 Finland

Idiopathic proctocolitis, Ulcerative (chronic) ileocolitis

17.2

21.8

XF400

NOMESCO Finland

ECG with 12 standard connections

1.7

21.8

448

2811

C24.8

ICD-10 Finland

Malignant neoplasm: Overlapping lesion of biliary tract

80.8

21.7

C24.09

ICD-10 Finland

Biliary duct or passage NOS

116.0

21.6

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

2.0

21.6

263

1405

XX1AT

NOMESCO Finland

Other puncture with ultrasound guidance

4.6

21.5

113

D99

ICPC

Disease digestive system other

5.1

21.4

JMA10

NOMESCO Finland

Transabdominal total splenectomy

8.3

21.4

256, ,

Kela drug reimbursment

26.6

21.3

K70.3

ICD-10 Finland

Alcoholic cirrhosis of liver

4.6

21.3

110

K76.0

ICD-10 Finland

Fatty (change of) liver, not elsewhere classified

3.3

21.1

238

WD115

NOMESCO Finland

Multiple cystostatic therapy of methastized malignancy

3.6

20.9

200

8000/3-C25.0

ICD-O-3

Neoplasm, malignant of head of pancreas

60.5

20.9

K81.8

ICD-10 Finland

Other cholecystitis

+∞

20.9

K85.2

ICD-10 Finland

Alcohol-induced acute pancreatitis

+∞

20.9

K86.01

ICD-10 Finland

Late effects of pancreatitis caused by alcohol

+∞

20.9

JKD50

NOMESCO Finland

Hepatoportoenterostomy

+∞

20.9

Z3226

NOMESCO Finland

Physiotherapist

1.7

20.9

483

3124

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

1.7

20.8

427

2675

JA3BT

NOMESCO Finland

Cathetrisation of abdominal cavity with X-ray guidance

15.9

20.6

103

Kela drug reimbursment

Diabetes, insulin-treated

1.5

20.5

713

5079

A11CC03

ATC

alfacalcidol; systemic

3.1

20.5

273

8160/3-C22.1

ICD-O-3

Cholangiocarcinoma of intrahepatic bile duct

25.7

20.4

WGA11

NOMESCO Finland

Planning of pain management

7.5

20.4

N18.9

ICD-10 Finland

Chronic kidney disease, unspecified

2.1

20.3

210

1058

A49.8

ICD-10 Finland

Other bacterial infections of unspecified site

5.3

19.9

JLB12

NOMESCO Finland

Transduodenal endoscopic incision of pancreatic duct orifice

+∞

19.8

Q44.21

ICD-10 Finland

Atresia of extrahepatic bile ducts

+∞

19.8

5761A

ICD-9 Finland

Other disorders of biliary tract, Cholangitis[CHOLANGITIS SUPPURATIVA]

+∞

19.8

WX110

NOMESCO Finland

Infiltration anesthesia

1.5

19.7

1761

15076

WX725

NOMESCO Finland

Noninvasive ventilation

2.3

19.7

154

694

K65.0

ICD-10 Finland

Acute peritonitis

4.5

19.6

109

H26.3

ICD-10 Finland

Drug-induced cataract

6.7

19.6

Z3231

NOMESCO Finland

Registered nurse

1.5

19.5

705

5054

E11.8

ICD-10 Finland

Type 2 diabetes mellitus, with unspecified complications

1.8

19.5

310

1803

K31.5

ICD-10 Finland

Obstruction of duodenum

40.4

19.5

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

2.1

19.5

205

1039

JAP00

NOMESCO Finland

Freeing of adhesions in the peritoneal cavity

4.9

19.5

E0000UV, ,

ATC

1.5

19.4

1038

8058

XX3DW

NOMESCO Finland

Time consuming IT work

1.8

19.4

294

1685

N03AX16

ATC

[U] pregabalin

1.6

19.3

552

3755

A41.4

ICD-10 Finland

Sepsis due to anaerobes

8.4

19.3

XF603

NOMESCO Finland

Direct intraarterial blood pressure measurement

2.6

19.2

114

453

D77

ICPC

Malignant digestive neopl other/NOS

7.9

19.2

OAB74

NOMESCO Finland

Nutritional guidance related to treatment and rehabilitation for medical condition

4.7

19.2

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

1.5

18.8

624

4385

TPH90

NOMESCO Finland

Removal of fixed intravenous catheter

4.1

18.8

130

8160/3-C24.0

ICD-O-3

Cholangiocarcinoma of extrahepatic bile duct

+∞

18.8

K83.2

ICD-10 Finland

Perforation of bile duct

+∞

18.8

K82.2

ICD-10 Finland

Perforation of gallbladder

+∞

18.8

57408

ICD-8 Finland

Cholelithiasis, Alia definita

+∞

18.8

Z53.8

ICD-10 Finland

Procedure not carried out for other reasons

8.1

18.8

A02BA02

ATC

ranitidine; systemic

1.6

18.7

481

3185

E13.8

ICD-10 Finland

Other specified diabetes mellitus, with unspecified complications

28.0

18.7

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

1.9

18.6

260

1451

5568X

ICD-9 Finland

Idiopathic proctocolitis, Other ulcerative colitis

14.2

18.6

PC2DE

NOMESCO Finland

Ultrasound examination of liver vasculature with Doppler method

191.3

18.5

JX1XE

NOMESCO Finland

Other ultrasound examinaton of alimentary organs

38.7

18.5

XX1XW

NOMESCO Finland

Extensive written report from radiologist

3.2

18.4

233

K73.0

ICD-10 Finland

Chronic persistent hepatitis, not elsewhere classified

44.3

18.2

T90

ICPC

Diabetes non-insulin dependent

1.5

18.1

614

4331

T89

ICPC

Diabetes insulin dependent

2.5

18.1

115

472

K44.9

ICD-10 Finland

Diaphragmatic hernia without obstruction or gangrene

2.0

18.0

213

1125

GD1AD

NOMESCO Finland

Thorax CT examination

2.1

17.8

180

899

123

Kela drug reimbursment

Chronic disorders of vitamin D metabolism

3.0

17.7

259

JL5AM

NOMESCO Finland

Bile and pancreas ducts simple MRI examination with 3 Tesla magnet

67.0

17.7

L04AA10

ATC

[U] sirolimus

67.0

17.7

JK1AT

NOMESCO Finland

Cathetrisation of bile cyst with radiological guidance

+∞

17.7

JJC60

NOMESCO Finland

Total excision of transplanted liver

+∞

17.7

8500/3-C25.0

ICD-O-3

Infiltrating duct carcinoma, NOS, of head of pancreas

+∞

17.7

JL5CM

NOMESCO Finland

Bile and pancreas ducts extensive MRI examination with 3 Tesla magnet

+∞

17.7

SPAT1083

SPAT

Initiation and monitoring of IV fluid therapy

2.4

17.7

129

564

KA2AE

NOMESCO Finland

Ultrasound examination transplanted kidney

6.4

17.6

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.6

17.5

469

3132

8140/3-C23.9

ICD-O-3

Adenocarcinoma, NOS, of gallbladder

181.1

17.5

JN5DR

NOMESCO Finland

PET-CT of upper body metabolism

3.8

17.4

142

A10AC01

ATC

insulin (human); parenteral

1.9

17.4

214

1145

Z94.9

ICD-10 Finland

Transplanted organ and tissue status, unspecified

29.0

17.4

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

2.4

17.4

121

518

TPH40

NOMESCO Finland

Insertion of a long peripheral venous catheter

5.0

17.4

K29.7

ICD-10 Finland

Gastritis, unspecified

2.6

17.3

386

D50.0

ICD-10 Finland

Iron deficiency anaemia secondary to blood loss (chronic)

2.5

17.3

112

464

138

Kela drug reimbursment

Severe anaemia associated with chronic renal failure

3.0

17.1

254

TJF80

NOMESCO Finland

Ostomy education

4.4

17.1

XX9TE

NOMESCO Finland

Compementary ultrasound examination

6.6

17.0

C25.8

ICD-10 Finland

Malignant neoplasm: Overlapping lesion of pancreas

16.0

17.0

XX9BW

NOMESCO Finland

Submitting image material and/or investigation material to authority or other institution

3.7

16.8

146

5741A

ICD-9 Finland

Cholelithiasis, Calculus of gallbladder with other cholecystitis[CHOLECYSTOLITHIASIS CUM CHOLECYSTITIDE CHR,SINE OBS]

+∞

16.7

JK3PB

NOMESCO Finland

Peroperative cholangiography

+∞

16.7

JKB21

NOMESCO Finland

Laparoscopic cholangioscopy

+∞

16.7

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

2.0

16.6

184

949

SPAT1254

SPAT

Administration of medicine

1.6

16.6

395

2560

ZXM00

NOMESCO Finland

Intraoperative use of ultrasonographic imaging

4.9

16.6

N02BE01

ATC

paracetamol; systemic, rectal

1.6

16.5

2293

20972

Q44.29

ICD-10 Finland

Atresia of bile ducts

171.0

16.5

JCA32

NOMESCO Finland

Endoscopic injection in oesophagus

23.2

16.4

KAS10

NOMESCO Finland

Allogenic transplantation of kidney from cadaver donor

5.4

16.4

K30

ICD-10 Finland

Functional dyspepsia

1.8

16.2

257

1492

JAD10

NOMESCO Finland

Repair of incisional hernia

5.9

16.2

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.4

16.1

974

7663

A28

ICPC

Limited function/disability NOS

1.5

16.1

517

3596

WZC10

NOMESCO Finland

Written specialist consultation based on a referral from a dentist or a physician

2.3

16.0

122

544

K72.1

ICD-10 Finland

Chronic hepatic failure

24.6

16.0

J01FF01

ATC

clindamycin; systemic

1.5

15.9

644

4701

ZXD30

NOMESCO Finland

Difficulties in perfomrming procedure

2.3

15.7

118

523

JK3RT

NOMESCO Finland

Percutaneous transhepatic removal of stones from bile ducts

+∞

15.6

K83.5

ICD-10 Finland

Biliary cyst

+∞

15.6

C25

ICD-10 Finland

Malignant neoplasm of pancreas

85.6

15.6

JLD12

NOMESCO Finland

Endoscopic drainage of pancreatic pseudocyst

85.6

15.6

JL5BM

NOMESCO Finland

Bile and pancreas ducts MRI examination with 3 Tesla magnet

85.6

15.6

D13.2

ICD-10 Finland

Benign neoplasm: Duodenum

5.6

15.5

L04AA05

ATC

[U] tacrolimus

38.3

15.4

JFH33

NOMESCO Finland

Total colectomy, mucosal proctectomy, ileoanal anastomosis and ileostomy

38.3

15.4

E87.6

ICD-10 Finland

Hypokalaemia

2.4

15.2

106

455

166

Kela drug reimbursment

Dalteparin and tinzaparin (treatment for more than 6 months)

4.5

15.2

GD1BD

NOMESCO Finland

Thorax extensive CT-examination

2.1

15.1

144

703

WX720

NOMESCO Finland

Own respiration

2.2

15.1

128

597

D12.6

ICD-10 Finland

Benign neoplasm: Colon, unspecified

2.1

15.1

153

765

6611

FHL

Needle biopsy in the operating room

45.2

15.1

SPAT1144

SPAT

Treatment of reopened or infected surgical wound

2.0

15.1

177

933

OAB50, ,

SPAT

1.9

15.0

202

1113

K56.0

ICD-10 Finland

Paralytic ileus

4.3

15.0

DM1AA

NOMESCO Finland

Paranasal sinuses X-ray examination without contrast

2.6

15.0

337

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

2.0

14.9

154

776

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

1.5

14.7

645

4769

RS220, ,

NOMESCO Finland

3.7

14.6

122

K83.4

ICD-10 Finland

Spasm of sphincter of Oddi

+∞

14.6

J01XX08

ATC

linezolid; systemic

5.1

14.6

M07.5*K51.9

ICD-10 Finland

Arthropathy in ulcerative colitis

11.9

14.6

TPH04, ,

SPAT

4.0

14.5

100

JF1AD

NOMESCO Finland

Small bowel CT

5.4

14.5

ZXH04

NOMESCO Finland

Procedure performed in other inpatient unit

5.8

14.5

JN1DM

NOMESCO Finland

Upper part of abdomen very extensive MRI examination with 3 Tesla magnet

36.2

14.4

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

1.5

14.4

618

4551

Y83.8

ICD-10 Finland

Other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.8

14.3

269

N18.8

ICD-10 Finland

Other chronic renal failure

2.7

14.3

292

A10AE05

ATC

insulin detemir; parenteral

2.1

14.3

146

732

B81

ICPC

Anaemia vit B12/folate deficiency

2.3

14.3

109

487

WZB00

NOMESCO Finland

Telephone prescription or other care instructions

1.4

14.3

654

4874

S18

ICPC

Laceration/cut

1.4

14.0

1160

9559

RD210, ,

NOMESCO Finland

3.3

14.0

160

L28

ICPC

Limited function/disability (L)

1.5

13.8

507

3617

1300

FHL

Esophagogastroduodenoscopy (also includes staining)

4.1

13.7

A02BC03

ATC

lansoprazole; oral

1.4

13.7

675

5091

PH1AE

NOMESCO Finland

Ultrasound examination of upper extremity veins

3.2

13.7

167

K92.2

ICD-10 Finland

Gastrointestinal haemorrhage, unspecified

2.4

13.6

371

D06

ICPC

Abdominal pain localized other

1.8

13.6

202

1149

5740A

ICD-9 Finland

Cholelithiasis, Calculus of gallbladder with acute cholecystitis[CHOLECYSTOLITHIASIS CUM CHOLECYSTITIDE AC,SINE OBST]

+∞

13.5

5770A

ICD-9 Finland

Diseases of pancreas, Acute pancreatitis[PANCREATITIS ACUTA NONALCOHOLICA NONHAEMORRHAGICA]

+∞

13.5

JLB35

NOMESCO Finland

Transduodenal endoscopic extraction of foreign body from pancreatic duct

+∞

13.5

8000/3-C24.9

ICD-O-3

Neoplasm, malignant of billiary tract, NOS

34.2

13.5

8000/3-C22.1

ICD-O-3

Neoplasm, malignant of intrahepatic bile duct

140.7

13.5

M80.4

ICD-10 Finland

Drug-induced osteoporosis with pathological fracture

5.2

13.4

E86

ICD-10 Finland

Volume depletion

2.5

13.4

320

8160/3-C24.9

ICD-O-3

Cholangiocarcinoma of billiary tract, NOS

25.9

13.4

ZXE60

NOMESCO Finland

More than 12 and less than 15 hours

4.5

13.3

SPAT1125

SPAT

Stoma care and guidance

3.0

13.2

197

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.4

13.2

983

7943

JN3KE

NOMESCO Finland

Abdominal ultrasound with added contrast

5.1

13.2

JFF10

NOMESCO Finland

Loop enterostomy

5.1

13.2

XF612

NOMESCO Finland

Measurement of central venous pressure

12.2

13.1

T81.9

ICD-10 Finland

Unspecified complication of procedure

3.1

13.1

172

ZY010

NOMESCO Finland

Hospital outpatient

2.1

13.0

121

587

K76.6

ICD-10 Finland

Portal hypertension

50.2

12.8

NK6MA

NOMESCO Finland

Measurement of bone age from hand and elbow using X-ray

4.6

12.8

GA4YT

NOMESCO Finland

Puncture of pleura with ultrasound guidance

2.3

12.8

439

N30.0

ICD-10 Finland

Acute cystitis

1.5

12.8

402

2773

K43.0

ICD-10 Finland

Incisional hernia with obstruction, without gangrene

4.6

12.6

NF1AA

NOMESCO Finland

Hip X-ray examination

1.7

12.5

244

1499

WX006

NOMESCO Finland

Intravenous sedation or analgesia without general anesthesia

1.9

12.5

172

955

T86.4

ICD-10 Finland

Liver transplant failure and rejection

+∞

12.5

JKC30

NOMESCO Finland

Partial excision of bile duct and anastomosis to jejunum

+∞

12.5

JJ9AT

NOMESCO Finland

Sampling of liver transplant under radiological guidance

+∞

12.5

JK2AT

NOMESCO Finland

Puncture of bile cyst with ultrasound guidance

+∞

12.5

5770D

ICD-9 Finland

Diseases of pancreas, Acute pancreatitis[PANCREATITIS ACUTA ALCOHOLICA NONHAEMORHAGICA]

+∞

12.5

XX4BW, ,

NOMESCO Finland

17.4

12.5

PD5AD

NOMESCO Finland

CT of aorta

2.6

12.4

272

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

1.6

12.4

333

2216

ZXK00

NOMESCO Finland

Conversion from percutaneous endoscopic to open procedure

4.9

12.4

SPAT1222

SPAT

Counselling/guidance promoting independent living

1.5

12.4

383

2631

S97

ICPC

Chronic ulcer skin

1.8

12.4

172

959

ZXE90

NOMESCO Finland

More than 22 hours

4.3

12.2

J01MA14

ATC

moxifloxacin; systemic

1.7

12.2

219

1317

A12AA04

ATC

calcium carbonate; oral

3.1

12.2

169

L04AG05

ATC

vedolizumab; parenteral

12.4

12.1

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

1.5

12.1

403

2811

V03AE01

ATC

polystyrene sulfonate; oral

3.3

12.0

139

JFH10

NOMESCO Finland

Total colectomy and ileostomy

13.4

11.9

R07.4

ICD-10 Finland

Chest pain, unspecified

1.4

11.9

672

5174

JDE01

NOMESCO Finland

Laparoscopic gastroenterostomy

46.9

11.9

B34.9

ICD-10 Finland

Viral infection, unspecified

2.5

11.8

303

K74.0

ICD-10 Finland

Hepatic fibrosis

11.7

11.8

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

1.5

11.8

465

3354

K70.4

ICD-10 Finland

Alcoholic hepatic failure

10.6

11.7

A41.0

ICD-10 Finland

Sepsis due to Staphylococcus aureus

2.7

11.7

222

C07AA05

ATC

propranolol; systemic

1.5

11.7

435

3100

N02BF02

ATC

pregabalin; oral

1.9

11.7

158

873

N05CF01

ATC

zopiclone; oral

1.4

11.7

776

6132

A06AC51

ATC

ispaghula, combinations; oral

2.1

11.7

113

556

UKC02

NOMESCO Finland

Cystoscopy

1.5

11.7

415

2932

XF600

NOMESCO Finland

Bloodpressure measurement

1.8

11.7

161

895

JLC10

NOMESCO Finland

Distal pancreatectomy

16.5

11.7

N17.8

ICD-10 Finland

Other acute renal failure

3.3

11.6

132

A04

ICPC

Weakness/tiredness general

1.5

11.6

396

2774

JF1DG

NOMESCO Finland

Small bowel very extensive MRI with with high intensity magnet

12.6

11.6

B01AA03

ATC

warfarin; systemic

1.4

11.6

523

3869

JL1AT

NOMESCO Finland

Biopsy of pancreas with ultrasound guidance

19.0

11.6

L04AA33

ATC

[U] vedolizumab

19.0

11.6

J02AC01

ATC

fluconazole; systemic

1.4

11.5

791

6279

SPAT1153

SPAT

Removal of sutures

1.4

11.5

732

5741

AA1AD

NOMESCO Finland

CT of head and brain

1.4

11.5

731

5734

C77.2

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Intra-abdominal lymph nodes

5.0

11.5

57403

ICD-8 Finland

Cholelithiasis, Choledocholithiasis

+∞

11.5

K82.9

ICD-10 Finland

Disease of gallbladder, unspecified

+∞

11.5

57709

ICD-8 Finland

Diseases of pancreas, Pancreatitis NUD

+∞

11.5

8000/3-C24.0

ICD-O-3

Neoplasm, malignant of extrahepatic bile duct

+∞

11.5

5714X

ICD-9 Finland

Chronic liver disease and cirrhosis, Chronic hepatitis[HEPATITIS CHRONICA ALIA SEU NUD]

+∞

11.5

K86.0

ICD-10 Finland

Alcohol-induced chronic pancreatitis

+∞

11.5

JK5ZT

NOMESCO Finland

Implantation of bile duct prosthesis with combined percutaneous transhepatic and endoscopic retrograde technic

+∞

11.5

OAB73

NOMESCO Finland

Prevention and treatment of malnutrition

3.8

11.5

JKD30

NOMESCO Finland

Extrahepatic anastomosis of right or left hepatic duct to jejunum

120.5

11.4

6664

FHL

Cholecystectomy and choledocotomy

120.5

11.4

8140/3-C24.1

ICD-O-3

Adenocarcinoma, NOS, of ampulla of Vater

120.5

11.4

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

1.7

11.4

231

1435

D69.6

ICD-10 Finland

Thrombocytopenia, unspecified

2.9

11.3

187

JN3DG

NOMESCO Finland

Very extensive MRI examination with high intensity magnet

8.3

11.3

A04AA55

ATC

palonosetron, combinations; systemic

2.3

11.3

385

E10.9

ICD-10 Finland

Type 1 diabetes mellitus, Without complications

2.2

11.3

450

FB1AD

NOMESCO Finland

CT examination of arteria pulmonalis

2.5

11.2

292

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

1.7

11.2

194

1155

JJ1AT

NOMESCO Finland

Puncture of lesion of liver with ultrasound guidance

25.1

11.1

8500/3-C25.9

ICD-O-3

Infiltrating duct carcinoma, NOS, of pancreas, NOS

25.1

11.1

KH1AD

NOMESCO Finland

CT of urinary organs

2.3

11.1

368

A10AE06

ATC

insulin degludec; parenteral

2.3

11.1

381

ZXE03

NOMESCO Finland

Procedure duration 20 to 29 minutes

1.9

11.1

135

721

XW000

NOMESCO Finland

Bone marrow biopsy

2.0

10.9

109

543

D70.82

ICD-10 Finland

Drug-induced neutropenia

3.1

10.9

148

JFC00

NOMESCO Finland

Entero-enterostomy

15.5

10.8

WPA13

NOMESCO Finland

Palliative consultation

5.1

10.8

Z49.1

ICD-10 Finland

Extracorporeal dialysis

3.3

10.7

124

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

1.7

10.6

202

1233

SPAT1301

SPAT

No procedures

1.4

10.6

731

5793

A07DA03

ATC

loperamide; oral

2.2

10.6

389

C08CA01

ATC

amlodipine; oral

1.3

10.5

972

8048

Q44.20

ICD-10 Finland

Atresia of intrahepatic bile ducts

110.4

10.4

JDA12

NOMESCO Finland

Endoscopic insertion of gastric stent

110.4

10.4

Q44.4

ICD-10 Finland

Choledochal cyst

+∞

10.4

JFG73

NOMESCO Finland

Excision of ileal pelvic pouch

+∞

10.4

Q44.3

ICD-10 Finland

Congenital stenosis and stricture of bile ducts

+∞

10.4

JJA21

NOMESCO Finland

Laparoscopic biopsy of liver

32.6

10.3

L29.9

ICD-10 Finland

Pruritus, unspecified

2.4

10.3

311

K76.89

ICD-10 Finland

Other specified diseases of liver

9.6

10.2

R50.8

ICD-10 Finland

Other specified fever

4.6

10.2

QX2XE

NOMESCO Finland

Ultrsound examination of soft tissue not elsewhere classified

2.2

10.2

357

R74.8

ICD-10 Finland

Abnormal levels of other serum enzymes

1.8

10.2

151

860

SPAT1149

SPAT

Suture or treatment of traumatic wound

1.5

10.1

286

1922

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.4

10.1

684

5398

N05BA04

ATC

oxazepam; oral

1.4

10.1

607

4705

Y69

ICD-10 Finland

Unspecified misadventure during surgical and medical care

3.1

10.0

129

K29.1

ICD-10 Finland

Other acute gastritis

3.5

10.0

TJD00

NOMESCO Finland

Insertion of nasogastric or naso-gastroduodenal tube

3.2

10.0

124

4AA12, ,

NOMESCO Finland

9.1

10.0

R60.0

ICD-10 Finland

Localized oedema

1.5

10.0

308

2110

7890A

ICD-9 Finland

Other symptoms involving abdomen and pelvis, Abdominal pain

2.0

10.0

105

534

JFA65

NOMESCO Finland

Endoscopic insertion of ileum stent

40.2

10.0

Z03.80

ICD-10 Finland

Observation for other suspected diseases and conditions

2.2

9.9

355

TPW99

NOMESCO Finland

Other minor surgical procedure on peripheral vessel or lymphatic system

3.3

9.8

110

R19.8

ICD-10 Finland

Other specified symptoms and signs involving the digestive system and abdomen

3.0

9.8

141

5739X

ICD-9 Finland

Other disorders of liver, Unspecified disorder of liver

26.1

9.8

I26.9

ICD-10 Finland

Pulmonary embolism without mention of acute cor pulmonale

1.8

9.8

138

773

E78.0

ICD-10 Finland

Pure hypercholesterolaemia

0.7

9.8

288

4128

57309

ICD-8 Finland

Other diseases of liver, Unspecified

10.6

9.8

N30.9

ICD-10 Finland

Cystitis, unspecified

1.8

9.8

154

893

107

Kela drug reimbursment

Pernicious anaemia

2.6

9.7

209

A10BH05

ATC

linagliptin; oral

1.8

9.7

132

731

N06AX11

ATC

mirtazapine; oral

1.3

9.7

779

6301

ZX120, ,

SPAT

3.0

9.7

142

E13

ICD-10 Finland

Other specified diabetes mellitus

13.4

9.7

4AA33, ,

NOMESCO Finland

55.2

9.6

M13.9

ICD-10 Finland

Arthritis, unspecified

1.7

9.5

168

1007

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

1.7

9.5

171

1030

JK3AT

NOMESCO Finland

Catherisation of bile duct with ultrasound guidance

100.4

9.4

JK3AN

NOMESCO Finland

Biliary tract isotope imaging

100.4

9.4

JKB01

NOMESCO Finland

Laparoscopic incision of bile duct

+∞

9.4

5745A

ICD-9 Finland

Cholelithiasis, Calculus of bile duct without mention of cholecystitis[CHOLEDOCHOLITHIASIS SINE CHOLECYSTITIDE,SINE OBSTR]

+∞

9.4

5745B

ICD-9 Finland

Cholelithiasis, Calculus of bile duct without mention of cholecystitis[CHOLEDOCHOLITHIASIS SINE CHOLECYSTITIDE,CUM OBSTR]

+∞

9.4

K82.8

ICD-10 Finland

Other specified diseases of gallbladder

+∞

9.4

57708

ICD-8 Finland

Diseases of pancreas, Pancreatitis acuta alia

+∞

9.4

57500

ICD-8 Finland

Cholecystitis and cholangitis, without mention of calculus, Cholecystitis acuta

+∞

9.4

K82.0

ICD-10 Finland

Obstruction of gallbladder

+∞

9.4

57400

ICD-8 Finland

Cholelithiasis, Cum cholecystitide acuta

+∞

9.4

C24.01

ICD-10 Finland

Cystic duct

+∞

9.4

I48

ICD-10 Finland

Atrial fibrillation and flutter

1.4

9.4

586

4564

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

1.4

9.3

457

3419

SPAT1216

SPAT

Assessment of functional ability

1.4

9.3

384

2785

D69.3

ICD-10 Finland

Idiopathic thrombocytopenic purpura

4.0

9.3

Q61.2

ICD-10 Finland

Polycystic kidney, autosomal dominant

4.7

9.3

TQW11

NOMESCO Finland

Vacuum treatment of wound

2.5

9.3

232

D12.3

ICD-10 Finland

Benign neoplasm: Transverse colon

2.3

9.3

300

4AB02, ,

NOMESCO Finland

9.5

9.3

JWE00

NOMESCO Finland

Reoperation for deep haemorrhage in gastroenterological surgery

13.7

9.2

ZYC01

NOMESCO Finland

Remote contact by phone

1.8

9.2

139

797

PD1AD

NOMESCO Finland

CT of abdominal aorta and branches

3.7

9.2

UJG02

NOMESCO Finland

Proctoscopy

2.5

9.1

228

SPAT1137

SPAT

Taking care of patient’s/customer’s hygiene

1.7

9.1

162

972

A03DA02

ATC

pitofenone and analgesics; systemic

2.8

9.1

159

XXA00

NOMESCO Finland

Clinical examination requiring general anaesthesia

4.6

9.1

5AB14, ,

NOMESCO Finland

15.6

9.0

K74.5

ICD-10 Finland

Biliary cirrhosis, unspecified

18.7

8.9

A46

ICD-10 Finland

Erysipelas

1.4

8.9

354

2551

I15.1

ICD-10 Finland

Hypertension secondary to other renal disorders

3.3

8.9

102

B25.9

ICD-10 Finland

Cytomegaloviral disease, unspecified

12.6

8.9

SPAT1229

SPAT

Assessment of need for aid

1.6

8.8

188

1185

SPAT1325

SPAT

Vaccination

1.3

8.7

796

6543

JFF13

NOMESCO Finland

Terminal enterostomy

7.6

8.6

B03XA02

ATC

darbepoetin alfa; parenteral

2.3

8.6

259

T81.3

ICD-10 Finland

Disruption of operation wound, not elsewhere classified

2.4

8.6

253

SPAT1211

SPAT

Application of soft bandage

1.6

8.5

200

1288

WX306

NOMESCO Finland

Lumbar epidural anesthesy

1.8

8.5

120

674

K73.8

ICD-10 Finland

Other chronic hepatitis, not elsewhere classified

90.3

8.4

JK1CB

NOMESCO Finland

Cholecysto- and choledochography with X-ray

90.3

8.4

N03AX12

ATC

[U] gabapentin; oral

1.4

8.4

344

2491

K29.0

ICD-10 Finland

Acute haemorrhagic gastritis

4.9

8.4

K70.1

ICD-10 Finland

Alcoholic hepatitis

6.7

8.4

XW4AT

NOMESCO Finland

Biopsy of other inner organ with ultrasound guidance

6.7

8.4

SPAT1249

SPAT

Treatment-related counselling outside office

1.3

8.3

859

7161

JLD00

NOMESCO Finland

Pancreaticojejunostomy

+∞

8.3

JLB42

NOMESCO Finland

Transduodenal endoscopic dilatation of pancreatic duct

+∞

8.3

JJC96

NOMESCO Finland

Other transplantation of liver or related operation

+∞

8.3

57402

ICD-8 Finland

Cholelithiasis, Cum cholecystitide et choledocholithiasi

+∞

8.3

5750A

ICD-9 Finland

Other disorders of gallbladder, Acute cholecystitis

+∞

8.3

A40.8

ICD-10 Finland

Other streptococcal sepsis

3.1

8.3

112

T81.2

ICD-10 Finland

Accidental puncture and laceration during a procedure, not elsewhere classified

3.5

8.2

C78.0

ICD-10 Finland

Secondary malignant neoplasm of lung

2.4

8.2

215

K57.2

ICD-10 Finland

Diverticular disease of large intestine with perforation and abscess

2.5

8.2

203

I10

ICD-10 Finland

Essential (primary) hypertension

1.3

8.2

1535

13746

SPAT1104

SPAT

Monitoring of emergency patient

1.7

8.2

147

884

KA2AT

NOMESCO Finland

Biopsy of transplanted kidney with ultrasound guidance

4.2

8.2

WYA20, ,

SPAT

3.7

8.2

A04AD12

ATC

aprepitant; systemic

2.5

8.2

192

C10AA07

ATC

rosuvastatin; oral

0.7

8.1

496

6293

A07AA02

ATC

nystatin; oral

1.7

8.1

133

780

M79.0

ICD-10 Finland

Rheumatism, unspecified

2.2

8.1

311

A02BX02

ATC

sucralfate; oral

2.0

8.1

467

L04AB02

ATC

infliximab; parenteral

4.5

8.1

K90.0

ICD-10 Finland

Coeliac disease

2.2

8.1

318

Z03.5

ICD-10 Finland

Observation for other suspected cardiovascular diseases

1.6

8.1

176

1113

7824A

ICD-9 Finland

Symptoms involving skin and other integumentary tissue, Jaundice, unspecified, not of newborn

33.4

8.1

E87.1

ICD-10 Finland

Hypo-osmolality and hyponatraemia

1.8

8.1

115

648

JDA55

NOMESCO Finland

Endoscopic dilatation of stomach, pylorus or anastomosis of stomach

11.7

8.1

ED1AA

NOMESCO Finland

Mandibular X-ray examination

4.0

8.1

JF1BD

NOMESCO Finland

Very extensive small bowel CT

6.8

8.1

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

1.4

8.1

310

2219

JDH35

NOMESCO Finland

Endoscopic insertion of duodenal stent

22.1

8.0

GA4AT

NOMESCO Finland

Cathetrisation of pleural cavity with ultrasound guidance

2.8

8.0

136

F32.9

ICD-10 Finland

Depressive episode, unspecified

1.5

8.0

247

1693

NA6BG

NOMESCO Finland

Sacro-iliac joint MRI examination with high intensity magnet

3.1

8.0

104

WX730

NOMESCO Finland

Conventional respirator

2.8

8.0

142

KA9AE

NOMESCO Finland

Ultrasound examination transplanted kidney

7.2

8.0

B03XA01

ATC

erythropoietin; parenteral

3.4

7.9

Z73.3

ICD-10 Finland

Stress, not elsewhere classified

3.0

7.9

115

K57.9

ICD-10 Finland

Diverticular disease of intestine, part unspecified, without perforation or abscess

2.3

7.9

244

J05AB11

ATC

valaciclovir; oral

1.4

7.9

315

2269

K59.1

ICD-10 Finland

Functional diarrhoea

1.7

7.8

126

736

TNX10

NOMESCO Finland

Arthrocentesis, unspecified region, unspecified region

1.7

7.8

144

873

GA1AE

NOMESCO Finland

Ultrasound examination of thorax

2.2

7.8

271

WW200

NOMESCO Finland

Immunization

2.2

7.8

297

SPAT1234

SPAT

Support of social functional capacity

1.7

7.8

133

790

L29.8

ICD-10 Finland

Other pruritus

2.9

7.8

127

O26.6

ICD-10 Finland

Liver disorders in pregnancy, childbirth and the puerperium

3.8

7.8

K29.6

ICD-10 Finland

Other gastritis

3.0

7.8

111

JDA42

NOMESCO Finland

Other endoscopic haemostatic procedure in stomach or pylorus

7.0

7.8

K73.89

ICD-10 Finland

Other long-term hepatitis, not classified differently

45.1

7.7

JLC40

NOMESCO Finland

Total pancreatoduodenectomy

45.1

7.7

WD505

NOMESCO Finland

Simple enzyme inhibitor or similar therapy of methastized malignancy

3.1

7.7

101

CJE20

NOMESCO Finland

Phakoemulsification with implantation of artificial lens in posterior chamber

1.3

7.6

836

7007

D37.2

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Small intestine

4.5

7.6

JDA08

NOMESCO Finland

Endoscopic removal of foreign body from stomach or pylorus

18.4

7.6

TJA40

NOMESCO Finland

Percutaneous local drainage of peritoneal cavity

18.4

7.6

JX1XB

NOMESCO Finland

Other X-ray examination of alimentary tract with contrast

18.4

7.6

JGB50

NOMESCO Finland

Mucosal proctectomy and ileoanal anastomosis

18.4

7.6

M81.9

ICD-10 Finland

Osteoporosis, unspecified

1.8

7.6

116

668

QBB10

NOMESCO Finland

Major dressing of wound of skin of trunk

2.0

7.6

395

Z04.9

ICD-10 Finland

Examination and observation for unspecified reason

1.9

7.5

530

J04AB02

ATC

rifampicin; systemic

2.8

7.5

124

WPA10

NOMESCO Finland

Proactive palliative care treatment plan

3.2

7.5

WVA20, ,

SPAT

1.9

7.5

459

I20.09

ICD-10 Finland

Unstable angina

1.7

7.5

138

837

NK4XE

NOMESCO Finland

Joint ultrasound examination not elsewhere classified

1.7

7.5

139

845

C08CA05

ATC

nifedipine; systemic

1.7

7.5

143

877

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

1.3

7.5

624

5051

A29

ICPC

General symptom/complaint other

1.4

7.5

321

2345

K59.09

ICD-10 Finland

Constipation, unspecified

1.6

7.4

161

1018

JLA00

NOMESCO Finland

Exploration of pancreas

80.3

7.4

JDH32

NOMESCO Finland

Endoscopic dilatation of duodenum

80.3

7.4

D13.5

ICD-10 Finland

Benign neoplasm: Extrahepatic bile ducts

80.3

7.4

XW2BT

NOMESCO Finland

Other cytological test with X-ray guidance

80.3

7.4

6615

FHL

Liver transplant

80.3

7.4

K51.4

ICD-10 Finland

Inflammatory polyps

80.3

7.4

A08.4

ICD-10 Finland

Viral intestinal infection, unspecified

2.0

7.4

378

K91.8

ICD-10 Finland

Other postprocedural disorders of digestive system, not elsewhere classified

13.4

7.4

JAD11

NOMESCO Finland

Laparoscopic repair of incisional hernia

3.3

7.4

C07AG02

ATC

carvedilol; oral

1.7

7.4

144

888

R52.0

ICD-10 Finland

Acute pain

2.0

7.3

379

XF602

NOMESCO Finland

Bloodpressure monitoring

2.8

7.3

126

K03.66

ICD-10 Finland

Tooth plaque

1.6

7.3

173

1118

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.3

7.3

772

6437

6672

FHL

Cholecocenterostomy

+∞

7.3

6673

FHL

Hepatic enterostomy

+∞

7.3

5770C

ICD-9 Finland

Diseases of pancreas, Acute pancreatitis[PANCREATITIS ACUTA NONALCOHOLICA RECIDIVANS]

+∞

7.3

1282

FHL

ERCP and sphincterotomy

+∞

7.3

57608

ICD-8 Finland

Other diseases of gallbladder and biliary, Dyskinesia viarum biliferarum

+∞

7.3

5762A

ICD-9 Finland

Other disorders of biliary tract, Obstruction of bile duct

+∞

7.3

BE00A, ,

NOMESCO Finland

+∞

7.3

UJK42

NOMESCO Finland

Peroral pancreaticoscopy

+∞

7.3

JX1LA

NOMESCO Finland

Kinetic X-ray of alimentary tract with pictures

9.4

7.3

ZXE05

NOMESCO Finland

Procedure duration 40 to 49 minutes

1.8

7.2

106

603

PG1PT

NOMESCO Finland

Extensive endovascular embolisation for bleeding with radiological guidance not elsewhere classified

6.2

7.2

K75.2

ICD-10 Finland

Nonspecific reactive hepatitis

15.8

7.2

L97

ICD-10 Finland

Ulcer of lower limb, not elsewhere classified

1.9

7.2

510

JAK03

NOMESCO Finland

Laparotomy and peritoneal irrigation

30.1

7.1

QDB05

NOMESCO Finland

Revision of wound of skin of lower limb

2.1

7.1

335

K29.3

ICD-10 Finland

Chronic superficial gastritis

2.0

7.1

390

PBL10

NOMESCO Finland

Construction of arteriovenous fistula from radial artery

3.3

7.1

137

Kela drug reimbursment

Uraemia requiring dialysis

3.4

7.1

K50

ICD-10 Finland

Crohn disease [regional enteritis]

7.9

7.1

R06.0

ICD-10 Finland

Dyspnoea

1.3

7.1

633

5164

R31

ICD-10 Finland

Unspecified haematuria

1.5

7.1

253

1786

WX199

NOMESCO Finland

Other local analgesia

1.9

7.1

455

D12.2

ICD-10 Finland

Benign neoplasm: Ascending colon

1.9

7.0

413

I80.8

ICD-10 Finland

Phlebitis and thrombophlebitis of other sites

2.7

7.0

129

R74.9

ICD-10 Finland

Abnormal level of unspecified serum enzyme

4.2

7.0

E87.5

ICD-10 Finland

Hyperkalaemia

2.3

7.0

232

NG1AA

NOMESCO Finland

Knee X-ray examination without contrast

1.4

7.0

279

2010

M10.9

ICD-10 Finland

Gout, unspecified

1.6

7.0

172

1122

TPH05

NOMESCO Finland

Open cannulation of peripheral vein

3.4

7.0

XPX08

NOMESCO Finland

Intraoperative flow measurement

3.0

7.0

102

X57

ICD-10 Finland

Unspecified privation

2.2

7.0

239

E27.3

ICD-10 Finland

Drug-induced adrenocortical insufficiency

4.4

7.0

J01CA08

ATC

pivmecillinam; oral

1.3

7.0

810

6827

SPAT1231

SPAT

Assessment of adjustments needed in living environment

2.3

6.9

233

ZX121

NOMESCO Finland

Central venous catheter

6.3

6.9

JFG40

NOMESCO Finland

Revision of enterostomy or colostomy without laparotomy

6.3

6.9

B01AF02

ATC

apixaban; oral

1.4

6.9

334

2488

J01CA04

ATC

amoxicillin; systemic

1.3

6.9

1979

18425

GD1DD

NOMESCO Finland

High resolution CT examination of lungs

1.7

6.9

117

695

ZXE70

NOMESCO Finland

Moren than 15 and less than 18 hours

7.5

6.9

JFH20

NOMESCO Finland

Proctocolectomy and ileostomy

13.8

6.9

C25.4

ICD-10 Finland

Malignant neoplasm: Endocrine pancreas

13.8

6.9

SPAT1217

SPAT

Assessment of need for services (elderly/care support)

1.5

6.9

192

1289

D48.5

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Skin

1.6

6.8

157

1008

SPAT1172

SPAT

Guidance concerning hydration

2.1

6.8

287

TKC20

NOMESCO Finland

Catheterisation of bladder

1.6

6.8

161

1042

R60.9

ICD-10 Finland

Oedema, unspecified

1.7

6.8

127

775

K25.9

ICD-10 Finland

Gastric ulcer, Unspecified as acute or chronic, without haemorrhage or perforation

2.4

6.8

179

C07AB02

ATC

metoprolol; systemic

1.3

6.8

490

3884

K23.8*B37.8

ICD-10 Finland

Esophagitis caused by candidiasis

5.7

6.7

JWW96

NOMESCO Finland

Other reoperation in gastroenterological surgery

16.7

6.7

R17.0

ICD-10 Finland

Hyperbilirubinaemia with mention of jaundice, not elsewhere classified

16.7

6.7

E000001, ,

ATC

1.3

6.7

418

3240

E03.9

ICD-10 Finland

Hypothyroidism, unspecified

1.4

6.7

273

1974

N18.4

ICD-10 Finland

Chronic kidney disease, stage 4

2.8

6.7

110

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.2

6.7

1028

8934

R73.9

ICD-10 Finland

Hyperglycaemia, unspecified

2.0

6.7

337

I50.9

ICD-10 Finland

Heart failure, unspecified

1.4

6.7

379

2898

I87.2

ICD-10 Finland

Venous insufficiency (chronic)(peripheral)

1.5

6.6

243

1723

A04.9

ICD-10 Finland

Bacterial intestinal infection, unspecified

3.7

6.6

OAB72

NOMESCO Finland

Weight control and weight loss guidance

4.0

6.6

J01DA01

ATC

[U] cefalexin

1.2

6.6

1413

12709

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

1.3

6.6

422

3284

ZXE02

NOMESCO Finland

Procedure duration 10 to 19 minutes

1.8

6.6

103

598

K21.9

ICD-10 Finland

Gastro-oesophageal reflux disease without oesophagitis

1.5

6.6

206

1416

B80

ICPC

Iron deficiency anaemia

2.1

6.6

291

B02.9

ICD-10 Finland

Zoster without complication

1.6

6.6

155

1002

C07AB07

ATC

bisoprolol; oral

1.2

6.6

1194

10558

ZY020

NOMESCO Finland

Telephone, letter or other consultation without direct patient contact

1.6

6.6

132

821

XX9TB

NOMESCO Finland

Complementary X-ray examination with contrast

10.0

6.5

D07AC01

ATC

betamethasone; topical

1.3

6.5

803

6802

290

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

1.3

6.5

410

3186

M81.8

ICD-10 Finland

Other osteoporosis

2.9

6.5

101

WVC10

NOMESCO Finland

Subcutaneous infusion of drugs

3.9

6.4

M07.4

ICD-10 Finland

Arthropathy in Crohn disease [regional enteritis]

70.0

6.4

QBB05

NOMESCO Finland

Revision of wound of skin of trunk

2.8

6.4

107

S29

ICPC

Skin symptom/complaint other

1.3

6.4

449

3540

UJF34

NOMESCO Finland

Left colonoscopy

3.4

6.4

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

1.3

6.4

612

5029

B19.9

ICD-10 Finland

Unspecified viral hepatitis without hepatic coma

14.3

6.4

JWA00

NOMESCO Finland

Repair of wound dehiscence in gastroenterological surgery

3.7

6.4

K26.9

ICD-10 Finland

Duodenal ulcer, unspecified as acute or chronic, without haemorrhage or perforation

3.0

6.3

XX6XT

NOMESCO Finland

Other intravascular therapy with radiological guidance

6.0

6.3

5560A

ICD-9 Finland

Idiopathic proctocolitis, Ulcerative (chronic) enterocolitis

11.0

6.3

A03CA02

ATC

clidinium and psycholeptics; oral

1.6

6.3

126

783

C17.0

ICD-10 Finland

Malignant neoplasm: Duodenum

18.1

6.3

5550A

ICD-9 Finland

Regional enteritis, Small intestine

18.1

6.3

3A422, ,

NOMESCO Finland

18.1

6.3

K62.5

ICD-10 Finland

Haemorrhage of anus and rectum

1.6

6.3

127

792

5772A

ICD-9 Finland

Diseases of pancreas, Cyst and pseudocyst of pancreas[CYSTA ET PSEUDOCYSTA PANCREATIS]

+∞

6.3

5761B

ICD-9 Finland

Other disorders of biliary tract, Cholangitis[CHOLANGITIS CHRONICA]

+∞

6.3

6653

FHL

Cholecocotomy or hepaticotomy and choledocoscopy (includes stone removal)

+∞

6.3

57609

ICD-8 Finland

Other diseases of gallbladder and biliary, Alii definiti sive NUD

+∞

6.3

JLT00

NOMESCO Finland

Extracorporeal shock wave lithotripsy of pancreatic duct

+∞

6.3

JKW98

NOMESCO Finland

Other transluminal endoscopic operation on biliary tract

+∞

6.3

JKF96

NOMESCO Finland

Other secondary operation on biliary tract

+∞

6.3

JJC10

NOMESCO Finland

Allogenic partial transplantation of liver

+∞

6.3

1260

FHL

Endoscopic retrograde cholangiography

+∞

6.3

Q44.1

ICD-10 Finland

Other congenital malformations of gallbladder

+∞

6.3

K82.4

ICD-10 Finland

Cholesterolosis of gallbladder

+∞

6.3

K29.4

ICD-10 Finland

Chronic atrophic gastritis

2.1

6.2

257

8240/3-C25.9

ICD-O-3

Neuroendocrine tumor, NOS, of pancreas, NOS

26.7

6.2

XX4XT

NOMESCO Finland

Other canalization with radiological guidance

26.7

6.2

Z46.8

ICD-10 Finland

Fitting and adjustment of other specified devices

2.0

6.2

332

Y88.3

ICD-10 Finland

Sequelae of surgical and medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.0

6.2

346

H01CB02

ATC

octreotide; parenteral

7.0

6.2

L30.9

ICD-10 Finland

Dermatitis, unspecified

1.3

6.2

441

3484

I48.9

ICD-10 Finland

Atrial fibrillation and atrial flutter, unspecified

1.5

6.2

193

1327

E10.8

ICD-10 Finland

Type 1 diabetes mellitus, With unspecified complications

2.7

6.2

115

EBA15

NOMESCO Finland

Extraction of multiple teeth

1.8

6.2

520

M05BA04

ATC

alendronic acid; oral

1.5

6.2

207

1444

D10

ICPC

Vomiting

1.7

6.2

109

656

H25.8

ICD-10 Finland

Other senile cataract

1.4

6.2

277

2039

K29.8

ICD-10 Finland

Duodenitis

3.4

6.1

H01CB03

ATC

lanreotide; parenteral

7.7

6.1

K91.4

ICD-10 Finland

Colostomy and enterostomy malfunction

7.7

6.1

X59

ICD-10 Finland

Exposure to unspecified factor

1.3

6.1

414

3248

SPAT1097

SPAT

Recording of ECG

1.4

6.1

313

2355

L98.4

ICD-10 Finland

Chronic ulcer of skin, not elsewhere classified

2.1

6.1

253

N25.8

ICD-10 Finland

Other disorders resulting from impaired renal tubular function

3.8

6.1

WPA15

NOMESCO Finland

Palliative care consultation with the patient and loved ones

3.8

6.1

WB113

NOMESCO Finland

Multiple adjuvant cytostatic therapy

1.7

6.1

553

J09

ICD-10 Finland

Influenza due to identified zoonotic or pandemic influenza virus

1.9

6.0

392

SPAT1167

SPAT

Insertion of urinary catheter

1.8

6.0

443

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

513

813

7.53

320.08

2.3

1.2

—

(3033658) Prothrombin time (PT) actual/Normal

1468

5787

4.30

312.86

15.5

4.0

87.33

86.94

0.22

1445

5660

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

1909

6632

7.17

307.65

8.2

2.2

62.67

56.82

u/l

1.95

1857

6093

(3005719) IgG [Mass/volume] in Serum or Plasma

906

1666

7.62

307.65

4.0

2.8

11.69

10.50

g/l

10.81

858

1535

(3024980) IgG subclass 4 [Mass/volume] in Serum

596

276

27.31

307.65

2.9

1.4

0.82

0.89

g/l

0.35

509

223

(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum

347

161

24.53

307.65

1.7

1.2

150.59

314.00

titre

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

579

392

18.45

307.65

6.9

3.3

257.48

1129.94

u/ml

0.72

537

361

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

461

622

8.71

307.65

2.6

1.3

9.84

18.26

iu/ml

—

(3023368) Bacteria identified in Blood by Culture

1723

6760

5.16

307.65

9.0

4.2

—

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

1806

7161

5.45

307.65

13.0

3.0

50.21

35.64

u/l

6.31

1752

6767

(3007566) Smooth muscle Ab [Titer] in Serum

759

539

19.08

307.65

2.4

1.2

78.25

88.46

titre

0.33

(3034770) Mitochondria Ab [Titer] in Serum

758

535

19.19

307.65

2.3

1.2

1056.47

981.25

titre

0.06

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

965

732

19.79

307.65

7.0

3.0

558.17

2284.51

u/ml

0.66

897

623

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

347

161

24.53

307.65

1.7

1.2

314.27

85.71

titre

5.70

110

(3032080) INR in Blood by Coagulation assay

2202

10943

6.12

307.65

24.5

16.8

1.22

1.31

inr

14.99

1954

9142

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

1322

2324

10.04

307.65

7.0

4.2

9.31

23.94

ug/l

1.63

1136

1897

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

1241

2125

9.83

307.65

6.3

2.0

0.19

0.21

g/l

7.62

1205

1956

(3028026) IgM [Mass/volume] in Serum or Plasma

822

1324

8.43

307.65

2.7

1.8

1.27

1.38

g/l

0.69

787

1213

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

928

1984

6.56

307.65

8.7

1.8

43.34

32.43

u/l

2.69

877

1658

(3024561) Albumin [Mass/volume] in Serum or Plasma

2107

10533

5.30

307.65

17.1

4.9

33.50

35.50

g/l

41.51

2049

9842

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

2365

11741

8.33

307.65

28.1

6.0

18.72

11.88

umol/l

35.66

2330

11168

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

1296

2243

10.05

307.65

11.2

2.4

18.68

7.73

umol/l

21.92

1230

1950

(40768441) Liver Pathology biopsy report

365

135

31.03

307.65

2.4

1.3

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

623

144

55.67

307.65

2.5

1.2

—

(3009445) Proteinase 3 Ab [Units/volume] in Serum

531

965

6.58

289.25

2.5

1.5

5.48

18.21

iu/ml

0.98

(3042936) Bacteria identified in Isolate by Culture

1015

3240

4.38

284.85

2.9

2.0

—

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

300

281

11.86

282.25

1.2

1.1

1.62

1.48

g/l

4.66

284

250

(3006922) Hepatitis E virus Ab [Presence] in Serum

220

123

19.36

276.43

1.2

1.1

—

(3023183) Ammonium ion [Moles/volume] in Plasma

359

458

8.87

268.67

5.5

2.7

35.20

36.01

umol/l

0.13

332

415

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

352

452

8.79

261.88

7.8

5.6

930.94

611.37

iu/ml

0.35

(3048689) Calprotectin [Mass/mass] in Stool

870

2683

4.28

251.95

5.6

2.5

187.39

138.91

ug/g

3.13

812

2145

(3037522) Nuclear Ab [Titer] in Serum

916

2933

4.19

251.90

2.4

1.3

558.11

497.59

titre

0.42

275

646

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

665

1686

4.89

247.89

2.3

1.6

—

(3000570) Elastase.pancreatic [Mass/mass] in Stool

366

541

7.65

240.89

1.6

1.3

178.43

310.80

ug/g

19.58

223

312

(3044640) Blood type and Crossmatch panel - Blood

1559

7357

3.59

235.55

4.8

2.5

—

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

996

3576

3.80

229.32

3.1

2.7

21.60

22.36

0.84

949

3322

(3004789) Transferrin [Mass/volume] in Serum or Plasma

1014

3867

3.57

210.04

3.2

2.6

2.32

2.29

g/l

1.08

957

3565

(3022145) Colonoscopy Study observation

764

2445

3.94

205.49

2.8

1.3

—

(3022948) Iron [Moles/volume] in Serum or Plasma

1049

4155

3.47

203.56

3.2

2.7

12.06

12.76

umol/l

2.11

1002

3865

(3020779) Urea [Moles/volume] in Serum or Plasma

731

2289

3.99

202.56

13.5

7.2

9.26

10.28

mmol/l

3.11

709

2190

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

1842

10381

3.35

194.20

5.1

2.8

—

estimate

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

291

431

7.43

190.09

1.5

1.3

345.69

247.23

u/ml

3.26

179

240

(3016650) Hepatitis A virus Ab [Presence] in Serum

246

300

8.91

189.58

1.1

—

(3013826) Glucose [Moles/volume] in Serum or Plasma

2181

13740

3.86

189.21

12.4

5.0

6.89

6.72

mmol/l

3.34

2142

13052

(3026250) Tacrolimus [Mass/volume] in Blood

149

18.48

184.74

49.5

37.6

6.79

7.11

ug/l

0.71

133

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

141

19.76

180.53

4.5

2.5

0.59

0.61

mmol/l

2.20

141

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

253

339

8.12

180.26

1.3

—

(3007164) IgA [Mass/volume] in Serum or Plasma

1036

4341

3.23

179.23

2.6

1.5

2.64

2.45

g/l

2.05

864

2586

(3017143) Hepatitis C virus Ab [Presence] in Serum

693

2300

3.69

173.78

1.7

1.6

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

280

438

7.01

173.58

1.7

1.5

—

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

277

444

6.83

167.68

1.6

1.4

22.57

18.06

u/ml

—

(3013650) Neutrophils [#/volume] in Blood by Automated count

2078

13176

3.38

167.65

20.3

9.5

4.41

4.15

e9/l

4.33

1908

11323

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

991

4205

3.12

165.51

2.7

1.9

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

230

306

8.11

164.62

1.1

1.0

—

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

2448

17326

4.82

164.13

33.6

7.6

158.19

78.73

u/l

137.58

2418

16370

(3010375) cycloSPORINE [Mass/volume] in Blood

138

16.84

163.68

37.6

32.2

125.63

126.69

ug/l

0.04

123

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

259

398

7.08

163.06

1.6

1.5

160.31

142.55

au/ml

1.01

124

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

2176

14305

3.51

162.52

14.0

3.1

171.90

45.33

u/l

106.43

2112

13338

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

1194

5672

2.96

162.07

4.6

2.4

—

(3024139) IgG subclass 3 [Mass/volume] in Serum

178

175

10.81

160.77

2.0

1.2

0.44

0.41

g/l

0.24

106

136

(3027135) IgG subclass 1 [Mass/volume] in Serum

178

175

10.81

160.77

2.0

1.2

7.67

6.83

g/l

1.47

106

135

(3028192) IgG subclass 2 [Mass/volume] in Serum

178

175

10.81

160.77

2.0

1.2

3.44

2.97

g/l

1.68

105

135

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

1946

12043

3.12

160.40

13.1

7.3

1.20

1.21

mmol/l

6.76

1715

10383

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

244

362

7.30

158.59

4.4

3.2

1300.86

1725.79

u/ml

0.15

(4062490) Immunoglobulin typing, IgG

175

176

10.55

155.51

1.9

1.2

—

(3019069) Monocytes/Leukocytes in Blood

1810

10888

2.94

154.79

13.7

6.6

8.92

9.00

0.55

1753

10193

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

766

2898

3.28

154.12

1.8

1.6

—

(3006504) Eosinophils/Leukocytes in Blood

1801

10866

2.91

152.01

13.6

6.5

2.80

2.86

0.49

1741

10175

(3022096) Basophils/Leukocytes in Blood

1795

10852

2.89

150.13

13.8

6.6

0.66

0.67

0.09

1740

10153

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

1792

10847

2.88

149.11

12.3

6.7

1.20

1.21

mmol/l

6.05

1719

9973

(3048929) Epstein Barr virus Ab [Presence] in Serum

325

679

5.29

148.76

1.5

1.3

—

(3003458) Phosphate [Moles/volume] in Serum or Plasma

812

3279

3.10

145.07

9.3

6.1

1.05

mmol/l

0.03

778

3041

(3002030) Lymphocytes/Leukocytes in Blood

1813

11134

2.85

144.99

13.7

6.5

25.53

27.30

9.27

1771

10548

(3018010) Neutrophils/Leukocytes in Blood

1786

10933

2.81

142.82

13.3

6.4

58.84

57.51

4.48

1749

10425

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

177

204

9.21

142.07

1.3

1.2

54.97

65.65

u/l

0.93

164

177

(3012095) Magnesium [Moles/volume] in Serum or Plasma

911

3968

2.94

141.56

6.4

3.4

0.79

0.82

mmol/l

11.62

883

3727

(3006315) Basophils [#/volume] in Blood

1868

11783

2.83

139.38

13.4

6.3

0.04

e9/l

0.14

1692

9958

(3001604) Monocytes [#/volume] in Blood

1863

11760

2.82

138.35

13.4

6.3

0.61

0.60

e9/l

1.04

1688

9936

(3019198) Lymphocytes [#/volume] in Blood

1888

12038

2.82

136.76

13.5

6.4

1.70

1.90

e9/l

9.68

1730

10459

(3013115) Eosinophils [#/volume] in Blood

1894

12157

2.80

134.27

13.7

6.5

0.20

0.19

e9/l

0.25

1723

10454

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

1235

6523

2.62

129.14

3.6

2.4

3.11

2.81

mg/l

3.30

1104

5583

(3042733) HLA Ab [Presence] in Serum

110

16.10

127.91

1.8

4.7

—

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

322

770

4.60

124.76

8.1

5.0

1.60

1.50

mg/l

1.18

311

700

(3018418) pH of Serum or Plasma

1291

7178

2.51

118.32

6.4

4.1

7.40

0.08

988

5141

(3034274) Bile acid [Moles/volume] in Serum --fasting

154

189

8.57

117.39

6.4

2.1

31.82

6.61

umol/l

6.19

140

131

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

203

344

6.29

115.64

7.6

5.9

12.46

11.78

mg/l

0.98

189

327

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

272

625

4.72

110.38

1.3

1.4

—

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

355

1007

3.90

108.95

2.2

1.9

2.84

2.20

ug/l

0.43

325

869

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

20.35

108.26

3.1

2.8

33.57

675.07

ug/l

0.46

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

1634

10375

2.42

108.07

4.5

2.4

75.36

77.72

nmol/l

2.88

1536

9277

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

724

3170

2.74

107.21

2.6

1.8

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

130

152

8.93

102.89

1.5

1.3

80.99

85.50

—

(4035726) Immunohistochemistry procedure

530

2012

3.03

101.94

1.8

1.4

—

(3018677) aPTT in Platelet poor plasma by Coagulation assay

780

3726

2.53

95.18

3.8

2.2

30.59

29.79

2.41

766

3621

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

113

122

9.62

95.01

1.9

1.5

4.36

5.47

u/l

0.31

(3002582) Erythrocytes [#/volume] in Urine

1306

7832

2.27

94.35

5.2

3.5

108.05

85.17

e6/l

0.15

1099

5963

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

669

2995

2.63

93.23

2.6

1.8

—

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

112

123

9.45

92.96

1.3

1.2

148.47

76.80

u/l

3.34

102

100

(3031040) Bacteria [#/volume] in Urine by Automated count

2054

14995

2.47

91.18

7.0

4.8

3627.02

1875.99

e6/l

0.38

213

(3012544) pH of Venous blood

618

2687

2.68

91.14

7.2

3.9

7.37

7.38

0.38

375

1572

(3024471) HLA-A [Type]

12.74

90.92

1.0

—

(3024932) HLA-DR beta [Type]

12.74

90.92

1.0

1.1

—

(40768797) Stomach Pathology biopsy report

670

3045

2.59

90.18

1.5

1.2

—

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

123

160

8.00

89.17

1.1

307.27

289.38

mg/l

1.11

113

140

(3021447) Carbon dioxide [Partial pressure] in Venous blood

610

2662

2.66

89.10

7.2

3.9

5.68

5.84

kpa

4.35

596

2586

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

107

118

9.40

88.51

1.3

1.2

39.54

17.48

u/l

1.87

(3000850) Epithelial cells [#/volume] in Urine

987

5411

2.29

86.81

4.1

2.7

7.06

5.15

e6/l

2.32

926

4898

(3002032) Base excess in Venous blood by calculation

592

2600

2.63

84.96

7.2

4.0

1.18

1.78

mmol/l

3.33

521

2215

(3001122) Ferritin [Mass/volume] in Serum or Plasma

1584

10568

2.18

84.33

4.5

3.1

148.99

132.11

ug/l

1.45

1490

9783

(3030467) Casts [#/volume] in Urine by Automated count

1149

6786

2.19

83.34

5.1

3.4

0.54

0.46

e6/l

0.41

947

4968

(3026782) Osmolality of Urine

876

4639

2.30

82.98

4.3

2.9

531.34

536.93

mosm/kgh2o

0.34

801

4032

(3018095) Leukocytes [#/volume] in Urine

1384

8853

2.14

81.02

6.2

4.1

49.99

97.63

e6/l

3.27

1111

6238

(3037467) Urinalysis macro (dipstick) panel - Urine

2065

15507

2.34

79.40

6.7

4.6

—

2.63

—

(3002256) Pathology report gross observation

619

2863

2.50

79.15

1.5

1.3

—

(3013707) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells by Westergren method

2163

16618

2.42

78.04

8.6

4.3

17.74

12.53

mm/h

32.23

2054

15520

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

631

2969

2.46

77.56

3.7

4.3

247.38

248.94

u/l

0.07

605

2810

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

133

223

6.22

76.26

1.2

—

(3000991) Gas panel - Venous blood

526

2295

2.60

75.73

15.1

8.9

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

194

458

4.48

75.57

1.3

1.2

—

(3027945) Reticulocytes/Erythrocytes in Blood

639

3069

2.41

74.75

3.4

2.7

1.93

1.77

2.35

579

2711

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

437

1749

2.78

74.62

13.9

8.8

24.35

24.90

mmol/l

2.32

431

1741

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

109

153

7.38

73.91

1.1

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

133

232

5.97

73.24

2.4

2.5

20.29

42.39

iu/ml

0.99

(36304419) Bacteria [Presence] in Urine

1077

6481

2.09

71.67

5.1

3.3

1.16

0.00

estimate

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

400

1568

2.82

70.85

1.4

1.5

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

269

855

3.38

68.51

1.8

1.7

0.34

0.30

mg/l

0.35

414

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

342

1259

2.96

67.89

1.7

1.5

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

250

763

3.50

67.84

1.6

1.3

—

(3026008) Bacteria identified in Urine by Culture

1139

7136

2.02

66.58

4.0

3.3

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

9.99

65.31

1.1

—

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

225

666

3.59

63.90

4.7

3.0

219.16

189.09

4.65

217

632

(3002173) Hemoglobin [Mass/volume] in Arterial blood

512

2373

2.42

63.88

13.3

8.2

112.95

121.40

g/l

15.89

505

2313

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

394

1612

2.69

63.87

2.1

1.7

—

(3016502) Oxygen saturation in Arterial blood

542

2584

2.37

63.41

12.9

7.9

96.36

95.22

5.54

533

2485

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

518

2421

2.40

63.39

2.2

1.8

1.53

1.50

0.58

451

2101

(3023520) Reticulocytes [#/volume] in Blood

511

2386

2.40

62.60

3.0

2.7

72.21

68.43

e9/l

1.09

384

1723

(3014111) Lactate [Moles/volume] in Serum or Plasma

501

2324

2.41

62.25

12.6

7.8

1.39

1.37

mmol/l

0.14

489

2275

(3019977) pH of Arterial blood

584

2898

2.29

62.11

12.5

7.6

7.41

7.42

0.23

297

1570

(3003396) Base excess in Arterial blood by calculation

581

2884

2.29

61.70

12.3

7.5

0.26

0.89

mmol/l

3.07

492

2381

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

388

1604

2.65

61.49

7.5

4.3

23.58

24.09

mmol/l

2.39

382

1586

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

27.73

60.25

3.2

4.4

—

(40768804) Tissue Pathology biopsy report

1316

8880

1.93

60.07

3.0

2.2

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

218

658

3.51

60.03

2.0

1.7

—

(3021589) Normoblasts [#/volume] in Blood

1462

10237

1.92

59.38

28.2

11.3

0.00

e9/l

0.36

1242

8267

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

11.30

58.94

1.1

—

(3027801) Oxygen [Partial pressure] in Arterial blood

574

2908

2.23

57.62

12.6

7.5

12.76

12.12

kpa

1.93

562

2787

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

347

1404

2.68

57.20

14.1

10.2

15.04

15.92

6.32

341

1350

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

573

2909

2.23

57.18

12.7

7.6

4.95

5.12

kpa

4.28

560

2787

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

1309

8926

1.89

56.81

6.0

3.9

36.85

119.42

ng/l

1.02

1056

6535

(3021601) Nitrite [Presence] in Urine by Test strip

1626

11913

1.90

56.10

5.5

3.9

0.00

estimate

0.50

408

2469

(3002179) Metamyelocytes/Leukocytes in Blood

437

1996

2.41

55.76

5.8

4.3

0.65

0.71

0.22

209

609

(3017181) Myelocytes/Leukocytes in Blood

450

2091

2.38

55.20

6.1

4.4

0.88

0.02

221

638

(3036481) Cortisol [Moles/volume] in Serum or Plasma

454

2119

2.37

55.12

2.9

2.2

357.18

377.18

nmol/l

1.09

433

1955

(3009261) Glucose [Presence] in Urine by Test strip

1646

12145

1.89

55.12

5.6

3.9

0.04

0.14

estimate

0.34

394

2374

(3035350) Ketones [Presence] in Urine by Test strip

1633

12060

1.87

54.06

5.6

3.9

20.10

3.68

estimate

1.31

419

2524

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

246

854

3.07

53.77

3.7

3.3

0.30

0.35

iu/ml

1.14

120

471

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

701

3945

2.04

52.99

4.2

3.2

2.47

2.06

e6/l

0.55

407

1947

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

487

2391

2.26

52.31

5.3

3.5

—

(40758558) Short blood count panel - Blood

1076

7041

1.87

51.74

12.6

6.3

—

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

116

6.98

51.37

1.2

115.68

79.51

u/l

2.28

104

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

303

1208

2.70

51.20

1.9

1.8

1.43

1.50

g/l

0.58

257

1042

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

117

6.92

50.97

1.2

35.96

25.33

u/l

0.89

105

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

737

4282

1.99

50.58

4.1

3.1

1.33

1.12

e6/l

0.68

447

2291

(3014007) Fractional oxyhemoglobin in Arterial blood

372

1650

2.45

50.33

15.9

9.7

94.66

93.78

2.67

372

1643

(3025941) Bacteria identified in Stool by Culture

280

1088

2.75

49.69

1.4

1.2

—

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

212

709

3.16

49.31

1.7

1.5

0.28

9.88

iu/ml

0.56

137

(3021440) Promyelocytes/Leukocytes in Blood

423

2008

2.31

49.00

6.2

4.4

0.06

0.12

1.62

193

555

(3015736) pH of Urine

1346

9577

1.80

48.10

4.7

3.5

6.21

6.26

0.93

753

5216

(3036489) Thrombin time

241

880

2.91

48.02

4.4

2.4

21.89

21.15

1.31

228

798

(3015377) Calcium [Moles/volume] in Serum or Plasma

1192

8211

1.80

47.26

5.6

3.5

2.33

2.36

mmol/l

9.95

1108

7446

(3025159) Blasts/Leukocytes in Blood

420

2017

2.28

47.22

6.4

4.6

0.05

0.28

0.85

176

523

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

805

4941

1.89

46.21

1.5

1.3

1.90

2.07

u/ml

0.12

191

1270

(40760892) CBC W Ordered Manual Differential panel - Blood

802

4919

1.89

46.13

8.2

4.7

—

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

795

4902

1.88

44.74

2.6

1.8

2.00

1.37

mg/l

2.31

661

3775

(3007853) Bacteria identified in Skin by Aerobe culture

517

2750

2.08

44.70

2.1

1.7

—

(3024354) Oxygen [Partial pressure] in Venous blood

447

2254

2.17

44.39

6.9

3.5

4.66

4.59

kpa

0.28

432

2186

(46236952) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)/1.73 sq M

387

1851

2.27

43.73

3.5

2.8

60.18

63.49

ml/min/173m2

0.79

178

790

(3003694) ABO and Rh group [Type] in Blood

958

6323

1.79

42.79

1.6

1.4

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

615

3535

1.95

42.55

2.0

1.9

—

(3000494) Fungus identified in Specimen by Culture

502

2697

2.05

42.01

1.9

1.4

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

228

867

2.78

42.00

2.1

1.9

—

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

7.46

41.59

3.6

2.1

1100.86

3225.58

u/ml

0.37

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

379

1835

2.24

41.46

5.7

3.7

1.22

1.23

mmol/l

1.36

358

1561

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

143

418

3.55

41.19

1.2

405.33

404.85

titre

0.00

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

363

1731

2.26

41.18

7.3

4.2

4.97

5.15

kpa

4.22

347

1664

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

2489

21960

2.43

41.15

51.0

16.2

32.31

25.26

mg/l

23.82

2423

18059

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

188

651

3.03

41.08

1.6

1.3

—

(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence

143

419

3.55

41.04

1.2

1.3

87.50

348.89

titre

—

(3023487) Leukocytes [#/volume] in Peritoneal fluid

7.57

40.77

2.3

2.4

3610.81

767.47

e6/l

0.58

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

239

947

2.67

40.61

2.3

2.0

—

(3027273) Bicarbonate [Moles/volume] in Venous blood

266

1120

2.52

39.89

5.5

3.2

24.42

25.19

mmol/l

2.96

257

1078

(3009343) pH of Capillary blood

353

1693

2.25

39.41

7.4

4.2

7.42

7.41

0.56

312

1403

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

320

1495

2.29

37.98

7.5

4.1

1.17

1.71

mmol/l

1.39

226

1105

(3044007) Cell count panel - Peritoneal fluid

7.89

37.90

2.3

2.0

—

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

1081

7606

1.69

37.11

3.6

3.3

1526.48

1587.33

ng/l

0.19

960

6583

(3026493) Urate [Moles/volume] in Serum or Plasma

902

6070

1.72

36.32

4.2

2.8

351.80

349.06

umol/l

0.29

829

5286

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

1405

10644

1.66

35.88

2.5

2.2

91.76

95.68

pmol/l

2.39

840

5575

(3004119) Hemoglobin [Mass/volume] in Venous blood

324

1557

2.23

35.85

5.9

3.3

119.64

128.83

g/l

10.55

315

1517

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

7.34

35.63

2.3

2.1

8586.57

28920.66

e6/l

0.37

(3004809) Band form neutrophils/Leukocytes in Blood

130

393

3.42

35.54

4.1

3.7

1.50

1.61

0.11

122

346

(3017732) Neutrophils [#/volume] in Blood

492

2772

1.94

35.44

4.4

3.1

4.24

4.45

e9/l

0.46

426

2368

(3012501) Base excess in Blood by calculation

148

488

3.15

35.14

5.2

4.4

2.65

2.78

mmol/l

0.26

103

336

(44786774) Adalimumab [Mass/volume] in Serum or Plasma

7.86

34.91

2.2

2.4

8.64

9.71

mg/l

0.43

(1616796) Gas panel - Central venous blood

155

528

3.05

34.81

4.8

3.8

—

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

7.26

33.93

4.0

4.7

8.06

8.77

mg/l

0.30

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

172

631

2.84

33.80

1.7

1.5

—

(3008152) Bicarbonate [Moles/volume] in Arterial blood

307

1477

2.21

33.79

9.4

6.1

23.80

24.55

mmol/l

2.75

297

1409

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

753

4922

1.73

33.10

2.0

1.7

434.99

27141178.47

pmol/l

3.74

648

4064

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

724

4691

1.74

32.79

4.8

3.9

109.38

655.95

ng/l

2.18

585

3831

(3019309) Folate [Moles/volume] in Red Blood Cells

670

4255

1.76

32.53

2.0

1.8

1224.25

1166.37

nmol/l

0.76

533

3174

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

1627

13028

1.61

31.33

3.5

2.8

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

254

3.84

31.18

1.1

—

(3021960) Folate [Moles/volume] in Serum or Plasma

987

7015

1.64

31.15

2.0

1.7

19.50

20.08

nmol/l

0.63

891

5910

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

357

1878

2.04

31.01

6.2

4.1

96.09

91.63

ng/l

0.40

320

1624

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

237

1067

2.34

30.47

6.7

4.6

1.57

1.60

0.13

230

999

(3029937) Albumin [Presence] in Urine by Test strip

938

6642

1.63

29.72

5.7

4.0

0.00

estimate

0.06

376

2231

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

1188

8903

1.59

29.70

5.6

3.9

1.38

0.29

estimate

0.36

367

2039

(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood

275

1338

2.17

29.29

5.2

3.0

1.14

1.16

0.20

275

1326

(3007930) Methemoglobin/Hemoglobin.total in Blood

219

977

2.35

28.72

7.0

4.8

0.88

0.87

0.18

212

916

(3019550) Sodium [Moles/volume] in Serum or Plasma

2487

22533

2.10

28.68

51.6

19.6

138.99

139.65

mmol/l

32.17

2473

22076

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

272

1330

2.16

28.59

5.3

3.0

0.69

0.61

3.22

272

1321

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

139

4.77

28.54

2.6

1.9

—

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

26.35

28.38

4.2

3.1

—

(3023103) Potassium [Moles/volume] in Serum or Plasma

2488

22577

2.09

28.06

51.7

19.7

3.94

3.99

mmol/l

16.42

2472

22075

(3035715) Granulocytes [#/volume] in Blood

119

397

3.09

27.70

4.9

3.4

4.46

4.23

e9/l

0.37

119

397

(3019060) Gas panel - Arterial blood

290

1472

2.08

27.63

6.4

4.3

—

(3041096) Erythrocytes [Presence] in Urine by Automated

878

6247

1.60

26.62

5.2

3.4

0.11

0.05

estimate

0.37

347

1908

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

161

647

2.58

26.45

2.0

1.6

—

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

721

4896

1.64

26.45

5.0

3.0

2.48

2.45

mmol/l

6.64

657

4399

(3026692) Albumin [Mass/volume] in Peritoneal fluid

6.65

26.39

1.5

9.44

14.26

g/l

3.03

(40761536) Microorganisms panel - Urine sediment

328

1783

1.95

25.73

6.4

4.0

—

(3035933) Granulocytes/Leukocytes in Blood

135

506

2.75

25.46

4.9

3.3

57.94

58.12

0.05

135

506

(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay

6.99

25.03

3.2

3.7

93.62

99.32

au/ml

—

(3015235) Bicarbonate [Moles/volume] in Capillary blood

191

854

2.33

24.87

4.1

3.0

24.04

24.85

mmol/l

1.95

184

842

(3047181) Lactate [Moles/volume] in Blood

167

705

2.46

24.73

7.0

5.4

1.30

1.32

mmol/l

0.13

147

615

(3019225) pH of Specimen

389

2274

1.83

24.31

5.7

4.5

7.38

7.35

4.30

324

1602

(3028626) Oxygen [Partial pressure] in Capillary blood

173

750

2.39

24.16

9.6

4.2

8.95

8.38

kpa

3.44

167

735

(3030981) Hyaline casts [#/volume] in Urine by Automated count

344

1939

1.89

24.13

3.2

2.5

0.48

0.47

e6/l

0.03

333

1863

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

148

605

2.53

23.47

1.9

1.6

—

(3014051) Protein [Presence] in Urine by Test strip

873

6354

1.55

23.30

4.0

3.0

0.14

0.05

0.41

172

(3022313) Gas panel - Capillary blood

241

1228

2.06

22.61

8.5

4.4

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

247

3.35

21.90

3.4

4.0

—

(3052851) Hemolysis interference index of Serum or Plasma

150

641

2.42

21.63

4.6

3.5

2.66

2.51

index

0.07

328

(40764999) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)/1.73 sq M

2311

20856

1.68

21.45

42.0

16.2

79.31

78.62

ml/min/173m2

0.71

2234

19336

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

204

1001

2.12

21.13

8.8

4.6

24.21

24.65

mmol/l

1.29

193

932

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

114

437

2.68

20.61

1.7

—

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

2491

23044

1.88

20.15

39.0

11.7

39.58

25.58

u/l

72.50

2465

22311

(3020682) Albumin/Creatinine [Ratio] in Urine

1000

7690

1.47

19.70

5.0

4.1

10.39

9.07

mg/mmol

0.28

673

4843

(3009508) Creatinine [Moles/volume] in Urine

1038

8048

1.47

19.57

4.2

3.4

7.02

7.53

mmol/l

3.46

893

6807

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

111

432

2.64

19.48

2.8

1.8

0.89

0.85

nmol/l

0.17

362

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

326

2.89

19.31

1.7

1.6

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

128

539

2.44

19.07

1.7

1.4

—

(3002331) Protein [Mass/volume] in Peritoneal fluid

5.82

18.84

1.2

1.4

17.63

26.86

g/l

2.45

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

166

3.67

18.83

1.3

1.1

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

126

532

2.43

18.67

1.7

1.3

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

126

532

2.43

18.67

1.7

1.3

—

(3020393) Adenovirus Ag [Presence] in Stool

7.06

18.66

1.9

1.3

—

(3017354) Segmented neutrophils/Leukocytes in Blood

257

3.09

18.61

3.8

3.6

63.26

58.30

1.25

218

(3021901) Oxygen saturation in Capillary blood

120

500

2.46

18.30

4.6

3.0

90.86

89.23

1.67

113

488

(3003327) Ova and parasites identified in Stool by Light microscopy

158

742

2.20

18.29

1.7

1.6

—

(3020630) Protein [Mass/volume] in Serum or Plasma

348

2132

1.72

18.25

2.3

2.6

65.72

66.22

g/l

0.52

320

1948

(44790049) Parainfluenza type 3 nucleic acid detection

320

2.84

18.20

1.9

1.4

—

(44790047) Parainfluenza type 1 nucleic acid detection

320

2.84

18.20

1.9

1.4

—

(44806118) Parainfluenza type 4 nucleic acid detection

320

2.84

18.20

1.9

1.4

—

(44790048) Parainfluenza type 2 nucleic acid detection

320

2.84

18.20

1.9

1.4

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

112

454

2.53

18.11

1.5

1.4

—

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

958

7402

1.45

18.00

2.8

2.2

274.11

230.68

u/l

0.23

919

7010

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

317

2.83

17.94

1.7

1.6

—

(3037121) Protein [Mass/volume] in Urine

174

860

2.09

17.68

3.9

3.8

309.28

293.73

mg/l

0.06

111

389

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

285

2.90

17.25

1.8

1.4

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

121

522

2.38

17.11

1.7

1.6

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

281

2.90

17.09

1.8

1.4

—

(3002385) Erythrocyte [DistWidth] in Red Blood Cells

2041

18193

1.48

16.95

55.1

20.2

14.32

13.69

59.05

2033

17928

(3011397) Hemoglobin [Presence] in Urine by Test strip

754

5617

1.47

16.92

4.8

3.8

0.13

0.11

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

283

2.88

16.88

1.8

1.4

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

119

4.00

16.73

1.2

1.4

—

(3023420) DNA double strand Ab [Units/volume] in Serum

176

894

2.04

16.61

1.7

9.52

7.29

iu/ml

0.16

205

(3020564) Creatinine [Moles/volume] in Serum or Plasma

2501

23383

1.78

16.48

56.7

21.3

82.86

79.90

umol/l

2.98

2487

23070

(3012516) Albumin [Mass/volume] in Urine

962

7541

1.42

16.31

4.2

3.5

41.34

49.18

mg/l

0.70

665

4886

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

4.35

15.93

4.2

2.7

1.45

0.99

0.49

(3000093) Morphology [Interpretation] in Blood Narrative

226

3.01

15.41

1.2

1.1

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

124

567

2.24

15.34

3.6

2.2

119.88

129.07

g/l

3.59

103

436

(3025468) Yersinia sp identified in Specimen by Organism specific culture

271

2.82

15.25

1.8

1.4

—

(3039000) Anion gap in Blood by calculation

109

474

2.35

15.17

8.8

6.3

11.48

11.39

mmol/l

0.09

103

417

(3018572) Chloride [Moles/volume] in Blood

109

475

2.35

15.10

8.8

6.3

106.12

105.17

mmol/l

1.40

103

418

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

106

458

2.37

14.97

1.8

1.4

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

220

3.00

14.87

2.6

2.8

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

375

2.50

14.75

1.7

1.4

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

271

2.78

14.68

1.8

1.4

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

273

2.76

14.48

1.8

1.4

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

4.69

14.47

1.2

1.1

—

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

175

935

1.93

14.31

1.7

1.9

41.09

38.94

u/l

0.63

157

828

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

224

2.90

13.82

1.6

1.3

1.21

1.54

nmol/l

1.30

200

(3009871) Measles virus Ab [Titer] in Serum

4.40

13.79

1.7

1.6

3591.11

2690.91

titre

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

386

2.40

13.42

1.1

1.3

—

20.86

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

3.98

13.16

1.1

1492.70

1527.95

miu/ml

0.07

(3051611) Lipemic interference index of Serum or Plasma

233

2.79

12.88

6.0

3.3

12.84

12.31

index

0.21

129

(3024891) Influenza virus A+B Ag [Presence] in Specimen

124

614

2.07

12.58

1.4

1.1

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

142

3.28

12.32

1.2

1.1

—

(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma

104

3.69

12.21

2.6

3.0

2176.50

1025.36

u/ml

0.73

104

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

144

3.23

12.05

1.2

1.1

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

160

884

1.86

11.83

2.4

2.6

—

(3022493) Free Hemoglobin [Mass/volume] in Plasma

103

3.63

11.61

1.5

4.6

70.33

72.08

mg/l

0.06

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

154

3.09

11.43

1.6

1.3

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

334

2.37

11.31

1.1

181.36

127.20

iu/ml

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

156

3.05

11.19

1.6

1.3

—

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

114

572

2.04

11.19

1.8

2.0

12.52

11.97

mg/l

0.24

106

532

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

106

3.52

11.14

1.5

1.3

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

106

3.52

11.14

1.5

1.3

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

212

2.72

11.06

1.3

1.5

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

212

2.72

11.06

1.3

1.5

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

212

2.72

11.06

1.3

1.5

—

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

312

2100

1.55

11.01

3.7

2.3

4.86

7.57

ug/l

3.21

266

1835

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

113

570

2.02

10.94

1.2

1.3

231.25

222.16

miu/ml

0.08

244

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

159

899

1.82

10.93

2.1

2.3

719.34

738.69

ug/l

0.01

153

847

(3037756) Immunofixation for Serum or Plasma

103

504

2.08

10.83

1.3

1.6

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

8.27

10.79

1.0

—

(3000012) Reticulocyte production index

383

2.23

10.56

1.9

2.2

0.99

0.88

1.04

263

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

116

599

1.98

10.53

1.3

1.1

—

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

3.66

10.52

1.2

1.9

44.45

99.64

umol/l

2.42

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

4.50

10.48

1.2

1.1

1233.33

680.00

titre

—

(3045424) Erythrocytes [Presence] in Urine

185

1110

1.71

10.38

2.7

2.2

0.00

0.74

estimate

0.51

341

(42529406) Shigella sp [Presence] in Stool by Culture

117

610

1.96

10.34

1.3

1.1

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

116

603

1.96

10.34

1.3

1.1

—

(4281824) Cell count and differential, peritoneal fluid

226

2.60

10.30

1.2

1.1

—

(3004451) EKG impression Narrative

130

3.11

9.90

1.7

1.3

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

147

2.96

9.77

2.1

2.8

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

236

2.49

9.45

1.4

1.7

—

(3010813) Leukocytes [#/volume] in Blood

2506

23921

1.55

9.36

66.5

24.7

7.19

6.80

e9/l

5.58

2477

23282

(3007461) Platelets [#/volume] in Blood

2504

23908

1.54

9.23

66.5

24.7

249.28

247.09

e9/l

0.71

2482

23356

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

432

2.07

9.22

5.5

3.2

9.92

9.43

pmol/l

0.16

432

(3024731) MCV [Entitic mean volume] in Red Blood Cells

2504

23912

1.54

9.18

66.3

24.6

91.10

91.23

0.74

2489

23601

(3035941) MCH [Entitic mass]

2504

23914

1.54

9.15

66.2

24.6

30.17

30.36

5.42

2488

23601

(3026361) Erythrocytes [#/volume] in Blood

2504

23915

1.54

9.14

66.4

24.7

4.27

4.47

e12/l

58.84

2475

23287

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

216

2.53

9.13

1.2

1.1

—

(3009542) Hematocrit [Volume Fraction] of Blood by calculation

2504

23916

1.54

9.12

68.4

25.2

38.26

40.34

20.75

2487

23592

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

121

3.09

9.09

1.1

1.6

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

121

3.09

9.09

1.1

1.6

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

121

3.09

9.09

1.1

1.6

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

121

3.09

9.09

1.1

1.6

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

259

2.39

9.08

1.4

1.6

—

(3000963) Hemoglobin [Mass/volume] in Blood

2504

23921

1.53

9.06

67.1

24.9

126.82

134.68

g/l

103.26

2488

23618

(37208534) Antinuclear antibody arbitrary concentration in serum

3.66

8.99

1.1

1.0

—

(3011412) CD3 cells [#/volume] in Blood

206

2.55

8.97

1.9

2.6

986.32

1206.78

e6/l

1.14

179

(40759836) Histone Ab [Presence] in Serum by Immunoblot

184

2.64

8.85

1.2

1.1

—

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

293

2042

1.49

8.74

3.0

219.02

227.66

ng/l

0.13

275

1865

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

101

532

1.93

8.71

1.2

1.1

6.45

7.60

eliau/ml

—

(3044242) Glucose [Moles/volume] in Arterial blood

135

2.92

8.70

2.6

2.3

8.29

7.76

mmol/l

0.45

135

(3019150) Specific gravity of Urine by Refractometry

659

5277

1.33

8.67

5.7

4.1

1.02

1.31

kg/l

0.50

476

3486

(3015171) Extractable nuclear Ab [Units/volume] in Serum

136

788

1.76

8.67

1.3

1.2

0.30

0.84

u/ml

—

(3014271) Vancomycin [Susceptibility]

120

3.03

8.58

3.0

2.8

—

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

9.00

8.52

1.9

1.4

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

244

2.36

8.36

1.0

1.1

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

3.76

8.34

1.2

1.1

—

(40759850) Jo-1 extractable nuclear Ab [Presence] in Serum by Immunoblot

190

2.55

8.32

1.2

1.1

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

196

2.53

8.31

1.8

1.6

—

(36660697) Celiac disease serology panel - Serum

255

1747

1.51

8.26

1.2

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

179

2.60

8.26

1.2

1.1

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

3.36

8.20

1.2

1.1

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

240

2.36

8.20

1.3

1.2

—

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

108

597

1.84

8.06

1.3

1.2

4.94

8.67

u/ml

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

164

2.65

8.04

1.6

1.5

—

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

112

629

1.81

7.95

1.3

1.2

37.17

41.10

u/ml

—

(3003181) Sodium [Moles/volume] in Urine

492

1.92

7.95

1.9

1.4

54.59

62.47

mmol/l

1.10

395

(1761482) Bacteria [#/volume] in Urine by Culture

101

550

1.87

7.91

6.9

4.4

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

184

2.53

7.82

1.2

1.1

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

184

2.53

7.82

1.2

1.1

—

(3034860) Kappa light chains.free [Mass/volume] in Serum

143

867

1.69

7.78

1.9

3.2

48.96

47.13

mg/l

0.19

116

724

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

107

597

1.82

7.76

1.3

1.2

1.40

3.61

u/ml

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

504

1.90

7.73

2.7

2.4

142.30

95.64

ug/min

0.34

312

(3045414) Leukocytes [Presence] in Urine

301

2160

1.44

7.71

2.7

2.2

0.02

0.01

estimate

0.14

428

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

142

867

1.67

7.53

1.9

3.2

55.97

71.61

mg/l

0.27

113

727

(3004716) Salmonella sp identified in Stool by Organism specific culture

154

961

1.64

7.51

1.3

—

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

446

1.93

7.46

1.3

1.2

72.00

46.09

u/ml

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

143

2.68

7.32

1.6

1.5

—

(3018333) Ribosomal P Ab [Presence] in Serum

173

2.51

7.25

1.2

1.1

—

(3026389) Candida sp identified in Specimen by Organism specific culture

271

2.16

6.98

1.2

1.3

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

177

2.45

6.93

1.2

1.1

—

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

127

775

1.67

6.78

1.9

3.1

1.41

2.73

ratio

1.52

440

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

149

2.57

6.77

1.6

1.5

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

3.31

6.69

1.4

1.2

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

139

2138

0.63

6.51

1.8

2.0

3.44

3.52

ratio

0.34

116

1675

(3016750) Collection duration of Urine

114

2.74

6.28

2.7

2.3

500.78

500.44

min

0.01

(4268621) Lupus anticoagulant assay

231

2.19

6.23

2.4

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

535

1.76

6.17

1.3

—

(3052592) Norovirus Ag [Presence] in Stool

3.97

6.16

2.3

1.3

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

280

2.06

6.08

1.2

1.4

352.42

313.51

pmol/l

0.16

242

(40768446) Kidney Pathology biopsy report

2.94

6.00

2.0

1.7

—

(3000330) Specific gravity of Urine by Test strip

172

1163

1.51

5.98

5.2

3.5

1.02

ratio

0.09

167

1052

(3009595) Pneumocystis jirovecii DNA [Presence] in Specimen by NAA with probe detection

191

2.27

5.90

1.3

1.5

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

3.30

5.86

1.2

1.3

10.34

9.46

ug/l

0.37

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

3.25

5.72

2.0

2.6

11.19

9.84

kpa

1.20

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

3.25

5.72

2.0

2.6

4.48

4.91

kpa

1.06

(42868678) Cholesterol non HDL [Moles/volume] in Serum or Plasma

1580

0.61

5.63

1.5

1.8

3.09

3.45

mmol/l

1.95

1106

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

154

1033

1.52

5.58

1.9

2.4

7.64

7.39

g/l

0.99

141

944

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

154

1033

1.52

5.58

1.9

2.4

4.32

4.17

g/l

1.28

141

944

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

153

2.37

5.48

2.1

3.0

177.80

214.07

e6/l

0.46

133

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

153

1033

1.51

5.38

1.9

2.4

3.84

3.66

g/l

0.91

141

945

(40761539) Cells [Type] in Urine sediment by Light microscopy

3.56

5.32

1.4

1.1

—

(40768443) Skin Pathology biopsy report

148

996

1.51

5.29

1.3

1.2

—

(3011985) Renin [Units/volume] in Plasma

304

1.93

5.22

1.3

1.4

126.17

76.99

mu/l

0.35

271

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

1823

17035

1.21

5.11

4.6

4.2

14.88

pmol/l

0.01

1681

15486

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

152

2.32

5.10

1.8

2.8

429.35

550.45

e6/l

0.62

123

(3017569) Oxygen content in Arterial blood

134

2.40

5.05

3.2

2.6

15.43

16.22

0.49

134

(3027923) C peptide [Moles/volume] in Serum or Plasma

122

2.48

5.04

1.5

1.4

1.03

1.28

nmol/l

0.75

(3004775) Volume in Urine collected for unspecified duration

153

2.30

5.03

2.7

2.5

772.75

624.04

0.95

(3020961) Endomysium IgA Ab [Titer] in Serum

147

1000

1.50

5.01

1.2

1.1

66.00

169.46

titre

—

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

2139

20325

1.24

5.00

5.6

5.2

2.08

1.96

mu/l

1.30

1985

18692

(3041672) Baker's yeast Ab [Presence] in Serum

5.44

4.91

1.2

1.1

—

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

100

2.62

4.89

1.6

1.7

0.89

3.92

u/field

1.05

(3003338) MCHC [Entitic Mass/volume] in Red Blood Cells

1940

18295

1.21

4.68

55.4

21.2

330.44

332.20

g/l

14.05

1930

18173

(3032057) Clostridioides difficile [Presence] in Stool

3.50

4.61

1.5

2.2

—

(3008536) Aspergillus sp Ab [Presence] in Serum

3.35

4.60

1.2

1.6

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

429

1.72

4.58

1.2

52.08

38.76

u/l

0.30

371

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

132

896

1.50

4.57

2.0

2.5

11.64

10.30

g/l

2.23

118

799

(3010838) Calcium [Moles/time] in 24 hour Urine

363

1.78

4.54

1.6

2.0

4.63

5.08

mmol/24h

0.38

315

(3051387) C reactive protein [Mass/volume] in Capillary blood

500

1.66

4.50

4.5

3.4

33.82

29.05

mg/l

0.63

353

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

2.60

4.30

1.2

1.7

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

2.60

4.30

1.2

1.7

—

(3044927) Protein electrophoresis panel - Urine

255

1.90

4.21

1.2

1.1

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

168

1216

1.41

4.18

2.4

—

(21494755) Public health laboratory ask at order entry panel

112

1637

0.67

4.17

1.3

1.4

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

2.92

4.17

1.4

1.5

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

2128

20321

1.21

4.15

5.1

4.3

1.31

1.27

mmol/l

2.07

1957

18537

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

2.54

4.13

1.2

1.7

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

508

1.61

4.02

2.3

2.2

969.29

6240.53

u/l

3.02

207

(3020191) Ethanol [Moles/volume] in Serum or Plasma

176

2.06

4.00

1.6

1.3

0.80

1.26

promille

0.98

139

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

296

1.81

4.00

1.8

2.3

26.61

21.80

mg/l

0.26

112

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

170

2.07

3.96

1.8

1.3

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

2230

21425

1.22

3.91

6.3

5.1

4.35

4.56

mmol/l

17.27

2083

19907

(3004616) Nuclear Ab [Presence] in Serum

271

1.82

3.83

1.2

—

(21494814) CD8 cells/Lymphocytes in Specimen

2.61

3.80

1.9

2.1

34.95

29.55

0.87

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

136

966

1.43

3.79

1.9

2.5

3.05

2.96

g/l

0.48

123

878

(3015822) Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection

12.02

3.76

1.0

—

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

2.65

3.73

1.4

1.6

13.60

14.90

pmol/l

0.63

(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma

2.80

3.68

1.2

10.41

11.74

pmol/l

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

2191

21052

1.20

3.64

5.9

5.2

6.17

5.95

mmol/l

9.17

2039

19174

(3003329) Lymphocytes/Leukocytes in Synovial fluid

190

1.96

3.63

1.4

27.50

27.89

0.02

114

(3022621) pH of Urine by Test strip

232

1813

1.31

3.55

3.4

2.8

6.03

6.07

0.38

159

1242

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

324

1.71

3.50

1.3

2.50

3.45

u/ml

0.42

117

(3027974) Hepatitis B virus e Ag [Presence] in Serum

6.17

3.50

1.0

2.0

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

340

2792

1.25

3.49

4.7

5.0

33.47

32.89

0.41

256

1816

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

200

1.91

3.48

2.0

1.5

27.14

22.03

u/ml

—

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

127

906

1.42

3.48

1.8

2.5

0.33

1.01

g/l

3.74

110

774

(3042111) Morphology [Interpretation] in Bone marrow Narrative

417

1.62

3.47

1.4

1.6

—

(1002224) Polysomnography panel

972

0.62

3.45

1.1

—

(3042631) Mycobacterium sp identified in Specimen

342

1.68

3.41

2.5

2.8

—

(3028433) Virus identified in Specimen by Culture

2.58

3.38

1.4

1.1

—

(3045142) Bone marrow Pathology biopsy report

290

1.74

3.38

1.3

—

(3002619) Bacteria identified in Specimen by Culture

3.11

3.37

1.2

—

(3020491) Glucose [Moles/volume] in Blood

154

2.02

3.35

1.6

2.8

7.48

6.93

mmol/l

0.55

100

(21494434) Karyotype in Bone marrow

232

1.82

3.34

1.1

1.2

—

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

2150

20668

1.19

3.33

8.5

6.4

40.94

39.46

mmol/mol

8.73

2019

19222

(3006245) CD3-CD19+ cells/cells in Blood

2.42

3.30

3.4

3.6

14.87

12.91

0.17

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

151

1121

1.37

3.29

1.2

1.1

1.02

1.46

u/ml

—

(3013945) Hepatitis B virus e Ab [Presence] in Serum

6.38

3.18

1.0

1.9

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

589

1.49

3.15

1.6

1.4

—

(3006109) Coagulation factor IX activity actual/normal in Platelet poor plasma by Coagulation assay

2.69

3.05

2.4

1.3

87.20

104.14

1.05

(4211845) Urine protein measurement

100

2.21

2.99

3.5

3.1

—

(3032185) JC virus DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection

10.01

2.98

4.6

7.8

—

(3003434) Protein [Mass/volume] in Pleural fluid

387

1.59

2.97

1.5

30.92

31.55

g/l

0.15

345

(1761868) Lipid panel - Serum or Plasma

713

7949

0.86

2.97

3.9

3.2

—

(3006571) Granulocytes/Leukocytes in Synovial fluid

234

1.76

2.96

1.4

1.6

66.75

63.95

0.15

147

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

415

3540

1.20

2.95

1.6

1.5

—

(3008295) Osmolality of Serum or Plasma

280

1.69

2.93

1.3

1.4

278.03

277.42

mosm/kgh2o

0.05

205

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

121

2.08

2.92

1.2

—

(3017704) Immunofixation for Urine

128

2.04

2.91

1.3

1.5

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

304

1.66

2.89

1.5

1.4

27243.34

72943.11

e6/l

0.97

170

(4015189) Microbial culture of sputum

2.59

2.87

1.5

2.3

—

(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection

6.68

2.87

5.7

5.1

—

(3042010) Triglyceride [Moles/volume] in Pleural fluid

3.17

2.85

1.3

1.1

1.41

2.57

mmol/l

—

(3023199) Leukocytes [#/volume] in Pleural fluid

337

1.61

2.83

1.5

1.4

2626.44

1839.70

e6/l

0.21

230

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

186

1.84

2.83

1.1

93.15

106.03

pmol/l

0.83

186

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

179

1.85

2.82

2.2

2.1

1.29

1.61

u/field

0.30

(3043410) Blood group antigens tested for on Red Blood Cells

2.47

2.79

1.8

1.9

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

650

0.59

2.72

1.2

1.1

0.66

0.65

ratio

—

(3006462) Nitrate [Presence] in Urine

2.18

2.67

2.9

3.3

—

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

296

1.63

2.66

1.2

1.1

115.71

113.13

0.16

273

(3002523) Influenza virus A Ag [Presence] in Specimen

367

1.56

2.65

1.2

1.1

—

(3003740) Influenza virus B Ag [Presence] in Specimen

368

1.56

2.62

1.2

1.1

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

321

1.60

2.61

1.4

1.2

4.06

4.58

u/ml

0.16

147

(44817194) Complement alternate pathway AH50 actual/normal in Serum by Immunoassay

2.73

2.54

1.2

1.1

97.33

87.11

0.42

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

2.87

2.54

1.4

—

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

449

3911

1.18

2.53

1.3

39.65

32.44

iu/ml

0.38

146

1167

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

101

737

1.38

2.52

1.8

2.5

0.00

g/l

-0.00

647

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

3.47

2.48

1.3

1.5

—

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

702

0.64

2.41

1.2

1.55

1.52

g/l

0.30

702

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

5.01

2.40

1.0

1.1

—

(3000060) B lymphocytes [#/volume] in Blood

2.35

2.38

3.1

3.6

0.08

0.31

e9/l

—

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

103

764

1.36

2.34

1.8

2.5

0.04

0.03

g/l

0.24

684

(40768806) Pleura Pathology biopsy report

283

1.60

2.34

1.7

1.6

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

164

1301

1.28

2.32

3.3

3.4

4.35

4.49

pmol/l

1.03

147

1158

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

276

1.60

2.31

1.4

1.5

0.36

0.32

nmol/l

0.16

212

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

545

1.42

2.31

1.5

—

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

2.19

2.31

1.4

1.2

845.20

131.41

ug/l

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

3.22

2.30

2.0

1.9

—

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

690

1.38

2.29

1.9

2.6

0.00

g/l

-0.00

646

(3009214) Lutropin [Units/volume] in Serum or Plasma

614

1.40

2.28

1.3

1.5

8.82

8.50

u/l

0.06

481

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

2242

21798

1.16

2.27

6.5

5.8

2.46

2.65

mmol/l

20.74

2082

20164

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

3.49

2.27

1.0

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

2.03

2.26

1.4

1.2

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

418

3655

1.17

2.25

1.3

6.47

11.30

u/ml

1.12

143

1359

(3010015) Selenium [Moles/volume] in Serum or Plasma

3.11

2.22

1.4

1.6

1.12

1.30

umol/l

—

(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection

5.56

2.21

1.0

1.1

—

(3008898) HLA-B27 [Presence]

652

1.38

2.20

1.1

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

2.08

2.17

1.4

1.1

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

129

1.87

2.16

1.0

1.1

—

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

4.29

2.15

1.2

—

(21494890) Protein electrophoresis panel - 24 hour Urine

235

1.63

2.14

1.3

2.0

—

(3035880) pH of Pleural fluid

152

1.78

2.12

1.2

1.4

7.36

7.41

0.47

105

(3035320) C reactive protein [Mass/volume] in Body fluid

184

1.69

2.04

4.5

2.6

31.52

32.14

mg/l

0.03

139

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

2.23

2.01

1.3

1.1

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

263

1.57

2.00

1.1

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

287

1.54

2.00

1.2

1.1

3.51

2.98

eliau/ml

0.17

118

(3028679) Herpes simplex virus Ab [Presence] in Serum

104

1.93

2.00

1.0

1.1

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

2187

21277

1.14

1.99

6.0

5.0

1.40

1.45

mmol/l

7.30

2025

19633

(40768795) Lymph node Pathology biopsy report

225

1.61

1.96

1.4

1.3

—

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

2.09

1.86

1.1

1.5

60.25

85.59

—

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

2.09

1.86

1.1

1.2

72.38

90.13

—

(3034426) Prothrombin time (PT)

2.13

1.82

1.3

28.21

28.77

0.14

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

3.05

1.80

1.1

1.2

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood by calculation

2.76

1.79

10.5

7.6

10.38

10.68

—

(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay

2.03

1.75

1.1

1.3

103.47

101.12

0.07

(3014037) CD3+CD4+ (T4 helper) cells/cells in Blood

132

1.75

1.73

2.0

2.8

37.30

38.73

0.12

(40768800) Prostate Pathology biopsy report

542

0.66

1.72

1.3

1.2

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

125

1.77

1.71

2.8

2.4

—

(4195642) Thrombophilia screening test

291

1.49

1.69

1.2

—

(40761872) Peanut recombinant (rAra h) 2 IgE Ab [Units/volume] in Serum

0.00

1.69

0.0

1.2

—

14.80

—

(3020876) Protein [Mass/time] in 24 hour Urine

283

1.49

1.69

1.9

2.2

1.03

1.42

g/24h

0.65

175

(3027456) Digoxin [Moles/volume] in Serum or Plasma

563

1.34

1.66

4.1

3.3

0.79

0.80

nmol/l

0.17

462

(3000475) Leukocytes [#/volume] in Synovial fluid

572

1.34

1.66

2.0

1.6

12472.61

14783.17

e6/l

0.29

385

(3000034) Microalbumin [Mass/volume] in Urine

188

1.60

1.66

2.8

2.9

18.55

22.19

mg/l

0.18

147

(3037692) Legionella sp identified in Specimen by Organism specific culture

1.98

1.64

1.3

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

310

1.46

1.64

1.1

—

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

229

1.54

1.62

1.1

—

40.92

—

(3019420) Tryptase [Mass/volume] in Serum or Plasma

120

1.76

1.62

2.1

1.6

10.85

8.73

ug/l

0.29

104

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

3.00

1.58

1.0

—

(3021387) Prolactin [Units/volume] in Serum or Plasma

660

1.30

1.52

1.8

1.6

385.45

299.24

mu/l

1.01

604

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

108

1.76

1.50

1.2

1.1

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

759

1.27

1.50

1.6

24.98

19.52

u/ml

0.24

158

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

448

4933

0.89

1.48

3.1

3.3

0.80

0.79

ug/l

0.05

292

3273

(3012441) Differential panel - Pleural fluid

301

1.44

1.47

1.5

—

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

2.50

1.45

1.0

1.3

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

3.13

1.44

1.8

2.4

—

(3016273) Islet cell 512 Ab [Units/volume] in Serum

2.73

1.43

1.0

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

2.25

1.40

1.1

—

(3023419) Bacteria identified in Sputum by Culture

348

1.39

1.37

3.3

2.5

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

127

1.66

1.36

3.3

3.9

—

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

2.94

1.36

2.0

3.4

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

720

0.74

1.35

1.5

1.8

6.22

3.66

mg/l

0.75

532

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

350

1.38

1.33

1.9

1.5

—

(3023709) Somatotropin [Mass/volume] in Serum or Plasma

1.81

1.31

2.5

3.2

3.37

1.50

ug/l

0.85

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

497

0.70

1.30

1.5

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

1.89

1.28

1.4

2.3

1.56

2.33

ratio

0.99

(3005570) Glucose [Moles/volume] in Urine

227

1.46

1.26

1.8

2.1

—

(3038026) Centromere Ab [Units/volume] in Serum

178

1.52

1.26

1.1

1.2

—

67.45

—

(3049717) Cytology report of Urine Cyto stain

115

956

1.21

1.20

2.5

2.7

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

1.88

1.18

1.0

—

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

102

1.67

1.16

1.1

1.2

1.10

1.06

ratio

—

(40760543) Extractable nuclear Ab [Presence] in Serum by Immunoblot

110

1.64

1.15

1.2

1.1

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

806

1.22

1.14

1.3

1.5

26.55

25.56

iu/l

0.09

662

(3045788) Cell count panel - Pleural fluid

283

1.38

1.14

1.5

1.4

—

(3027035) Albumin [Mass/time] in 24 hour Urine

2.34

1.12

1.0

1.3

—

629.33

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

959

9125

1.08

1.12

2.3

1.9

1.37

1.34

mmol/l

0.56

828

7689

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

268

1.39

1.10

3.6

4.0

—

(4146454) Self-monitoring of blood glucose

243

1.40

1.09

2.2

2.8

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

260

1.39

1.09

1.2

1.3

—

nmol/l

—

(3015302) Jo-1 extractable nuclear Ab [Units/volume] in Serum

2.38

1.09

2.8

1.4

—

(3036670) Protein [Mass/volume] in Synovial fluid

1.82

1.09

1.2

36.13

39.44

g/l

—

(3020911) Cortisol [Moles/time] in 24 hour Urine

1.82

1.09

1.6

88.17

607.45

nmol/24h

0.64

(3013166) Neutrophils/Leukocytes in Synovial fluid

1.82

1.09

1.3

1.2

62.37

58.56

0.13

(3006442) Creatine [Moles/volume] in Serum or Plasma

144

1.53

1.08

2.3

1.5

82.55

84.10

umol/l

0.08

144

(3043238) Trisomy 21 risk [Likelihood] in Fetus

267

0.63

1.07

1.6

1.5

—

(3002079) Sodium [Moles/time] in 24 hour Urine

1.69

1.07

1.3

155.67

170.49

mmol/24h

0.41

(4024509) Urine culture

126

1071

1.18

1.06

2.5

2.0

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

1.93

1.06

1.7

1.6

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

2.12

1.05

1.3

1.1

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

2.12

1.05

1.3

1.1

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

2.12

1.05

1.3

1.1

—

(3033099) Centromere Ab [Titer] in Serum

2.12

1.05

1.0

1.2

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

306

1.35

1.03

1.1

1.2

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

2.27

1.03

2.4

1.5

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

122

1.56

1.02

1.0

—

(3022689) Creatine [Moles/volume] in Urine

1.77

1.00

1.3

1.4

5.95

7.72

mmol/l

1.14

(3038071) Oxygen [Partial pressure] in Mixed venous blood

1.88

1.00

9.4

7.1

5.72

5.30

kpa

—

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

1.88

1.00

3.4

2.3

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

1.88

1.00

3.4

2.3

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

282

1.35

1.00

1.2

1.3

0.20

0.24

nmol/l

0.27

232

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

123

1.55

0.99

1.1

—

(3047189) Immunofixation for 24 hour Urine

115

1.57

0.99

1.2

1.6

—

(3005322) IgE [Units/volume] in Serum or Plasma

159

1387

1.16

0.99

1.4

1.3

182.02

222.72

u/ml

0.56

144

1289

(3036048) Francisella tularensis Ab [Titer] in Serum

1.84

0.98

1.1

—

(3003191) Choriogonadotropin [Presence] in Serum or Plasma

353

1.31

0.98

1.7

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

100

1.60

0.96

1.2

1.1

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

259

0.65

0.96

1.5

1.4

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

1.67

0.91

1.0

—

(3013637) Mi-2 Ab [Presence] in Serum

1.67

0.91

1.0

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

1.67

0.91

1.0

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

1.67

0.91

1.0

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

312

0.70

0.88

1.5

1.4

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

1010

0.84

0.88

2.5

2.1

—

(3001686) Cold agglutinin [Titer] in Serum or Plasma

1.86

0.87

1.1

1.3

—

145.75

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

842

0.83

2.5

2.0

—

(42529528) Centromere protein B Ab [Units/volume] in Serum by Line blot

1.74

0.82

1.0

1.1

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

160

1422

1.13

0.80

1.1

1.3

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

147

1.43

0.80

2.2

1.8

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

147

1.43

0.80

2.2

1.8

—

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

1.73

0.79

1.3

0.57

0.31

ug/l

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

120

1047

1.15

0.79

1.0

1.1

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

242

1.33

0.78

1.1

1.5

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

316

0.73

0.78

1.5

1.4

1.15

1.16

ratio

0.02

193

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

316

0.73

0.78

1.5

1.4

0.97

0.94

ratio

0.21

193

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

316

0.73

0.78

1.5

1.4

1.40

1.21

ratio

0.30

193

(42528717) Cashew nut recombinant (rAna o) 3 IgE Ab [Units/volume] in Serum

0.00

0.78

0.0

1.2

—

5.53

—

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

1.52

0.75

1.2

1.6

38.97

40.15

g/l

0.30

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

1.57

0.75

1.1

—

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

2.09

0.74

1.0

115.20

86.67

titre

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

2.09

0.74

1.0

1.1

—

(4034850) Laboratory test

698

1.18

0.74

18.3

10.8

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

133

1.43

0.73

1.0

1.1

—

(3032352) Blasts [#/volume] in Cerebral spinal fluid

2.00

0.72

1.2

4.3

—

(3024263) Appearance of Synovial fluid

117

1.46

0.71

1.8

1.6

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

152

1359

1.13

0.71

1.2

117.23

142.11

u/ml

0.27

482

(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum

1.75

0.71

1.1

19.37

43.29

mg/l

—

(3011335) Digoxin [Mass/volume] in Serum or Plasma

1.85

0.68

2.6

3.2

0.96

0.67

ug/l

—

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

118

0.59

0.67

1.6

6.7

—

57.82

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

102

1.47

0.67

1.4

1.1

—

(3029396) Erythrocyte agglutination [Presence] in Blood

1.79

0.66

2.2

2.7

—

(3036071) Salmonella sp Ab [Titer] in Serum

1.57

0.65

1.0

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

221

2030

1.10

0.64

1.5

—

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

166

0.66

0.64

1.0

62.33

43.63

ng/l

—

112

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

172

1.34

0.63

1.1

1.3

2.16

2.23

mmol/l

0.14

163

(3001019) Free T4 and TSH panel - Serum or Plasma

868

0.86

0.62

1.8

1.7

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

618

1.17

0.62

1.2

1.3

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

1.63

0.62

1.3

1.1

—

(40765096) Chromosome analysis panel by Banding

1.48

0.60

1.0

1.1

—

(40761871) Peanut recombinant (rAra h) 3 IgE Ab [Units/volume] in Serum

0.00

0.60

0.0

1.0

—

0.10

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

141

0.64

0.60

1.0

1.1

—

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

148

1.35

0.59

1.8

1.7

108.68

119.41

ng/l

0.30

148

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

0.00

0.59

0.0

1.0

—

9.30

—

(3006653) Thiamine [Moles/volume] in Blood

112

0.62

0.58

1.3

1.2

140.14

141.60

nmol/l

—

112

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

115

0.61

0.57

2.7

1.9

—

(3051101) Glucose [Moles/volume] in Cord blood

1.72

0.57

2.7

5.9

11.32

8.52

mmol/l

—

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

1.72

0.57

1.2

1.5

—

(40757373) Influenza virus identified in Isolate

1.48

0.57

1.6

1.4

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

241

0.75

0.56

1.5

1.7

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

637

6629

0.95

0.55

4.4

4.6

22.47

22.00

0.31

316

3329

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

1.42

0.54

1.0

1.1

—

(3030862) Granulocytes [#/volume] in Cerebral spinal fluid

1.45

0.53

1.0

1.3

—

10.56

—

(3020650) Glucose [Presence] in Urine

1.47

0.50

1.5

2.0

0.00

0.04

estimate

0.49

(43534046) Estradiol (E2) [Moles/volume] in Serum or Plasma by High sensitivity method

1.43

0.46

1.0

1.9

0.13

0.11

nmol/l

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

221

1.22

0.42

1.1

1.2

—

(3032773) Endomysium IgG Ab [Titer] in Serum

221

1.22

0.42

1.0

1.1

—

(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method

0.00

0.41

0.0

1.0

—

(3024316) Viscosity of Plasma

0.00

0.41

0.0

1.5

—

1.56

—

(40766207) Peanut recombinant (rAra h) 8 IgE Ab [Units/volume] in Serum

0.00

0.41

0.0

1.0

—

6.25

—

(40767665) Peanut recombinant (rAra h) 9 IgE Ab [Units/volume] in Serum

0.00

0.41

0.0

1.0

—

1.96

—

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

0.00

0.40

0.0

1.1

—

(3016018) Differential panel - Cerebral spinal fluid

259

1.20

0.40

1.1

1.7

—

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

0.00

0.40

0.0

1.0

—

0.25

—

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

0.00

0.40

0.0

1.1

—

0.50

—

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

1.43

0.39

11.4

15.3

4.90

5.85

mmol/l

—

(40761873) Peanut recombinant (rAra h) 1 IgE Ab [Units/volume] in Serum

0.00

0.39

0.0

1.0

—

0.08

—

(3023511) Choriogonadotropin [Units/volume] in Urine

251

1.20

0.39

1.2

—

(3011288) Drugs identified in Urine by Screen method Nominal

532

1.13

0.39

1.7

2.7

—

(3019832) Treponema pallidum Ab [Presence] in Serum

155

1660

0.93

0.37

2.0

1.7

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

1.43

0.35

1.0

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

1.40

0.35

1.3

1.5

1.13

1.17

mmol/l

—

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

161

1511

1.07

0.34

2.5

2.4

21.29

20.02

au/ml

0.08

146

(3015183) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells

1.32

0.33

1.2

17.00

10.00

mm/h

0.45

(4010399) Spirometry for bronchospasm with prolonged evaluation after bronchodilator

185

1746

1.06

0.33

1.5

1.4

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

133

0.75

0.33

2.7

1.9

—

(3027231) Wheat IgE Ab [Units/volume] in Serum

1.31

0.33

1.0

0.19

6.92

u/ml

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

198

2087

0.94

0.31

2.1

2.4

14.18

13.12

nmol/l

1.09

170

1877

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

314

1.15

0.31

1.2

1.1

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

1.27

0.30

1.0

1.4

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

1.25

0.29

1.0

1.6

—

(3000764) Benzodiazepines [Presence] in Urine

764

0.91

0.29

1.6

2.0

—

(3005082) Progesterone [Moles/volume] in Serum or Plasma

1.23

0.29

1.1

1.2

47.30

33.39

nmol/l

—

(3024666) Lithium [Moles/volume] in Serum or Plasma

110

0.73

0.28

13.0

12.3

0.60

0.61

mmol/l

—

103

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

574

1.10

0.28

1.4

2.0

2.15

4.13

iu/l

4.06

221

(3010726) Horse dander IgE Ab [Units/volume] in Serum

364

0.88

0.27

1.1

1.41

1.54

u/ml

0.04

197

(3050129) First trimester maternal screen panel - Serum or Plasma

385

0.88

0.27

1.3

1.4

—

(3027944) Amphetamines [Presence] in Urine

760

0.92

0.26

1.6

1.9

—

(3028707) Methadone [Presence] in Urine by Screen method

321

0.87

0.26

1.8

2.7

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

185

1939

0.95

0.26

2.2

2.1

—

(3028300) Cannabinoids [Presence] in Urine

769

0.92

0.26

1.6

2.0

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

842

8269

1.03

0.25

5.1

5.7

2.53

3.63

ug/l

0.96

748

7442

(3014133) Dog dander IgE Ab [Units/volume] in Serum

319

0.88

0.25

1.1

1.63

4.20

u/ml

1.60

173

(3020874) Milk IgE Ab [Units/volume] in Serum

124

1.21

0.24

1.0

1.1

1.80

1.02

u/ml

—

(3027008) Opiates [Presence] in Urine

765

0.93

0.23

1.6

2.0

—

(4094501) Cardiovascular stress test using bicycle ergometer

639

0.92

0.22

1.2

1.1

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

274

0.87

0.22

1.1

0.19

0.29

u/ml

0.33

103

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

178

0.84

0.22

1.2

1.79

2.27

u/ml

—

(3018081) Beta-2-Microglobulin [Mass/volume] in Urine

0.00

0.21

0.0

1.4

—

10.83

—

(3001556) Androgen free Index in Serum or Plasma

0.00

0.21

0.0

1.1

—

(3038864) risperiDONE [Moles/volume] in Serum or Plasma

0.00

0.21

0.0

1.0

—

20.00

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

145

0.83

0.21

1.3

1.2

—

(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay

0.00

0.21

0.0

1.0

—

(3018562) Neutrophils/Leukocytes in Cerebral spinal fluid

0.00

0.21

0.0

1.3

—

39.75

—

(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma

0.00

0.20

0.0

1.2

—

2.71

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

1.22

0.20

1.0

1.3

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

269

1.12

0.19

1.5

1.6

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

1.22

0.19

1.0

1.1

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

291

0.89

0.19

1.1

6.12

6.46

u/ml

0.02

141

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

170

1765

0.96

0.18

2.1

2.0

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.19

0.18

1.0

1.1

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

609

0.93

0.17

1.5

2.0

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

277

2698

1.03

0.16

1.5

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

162

0.86

0.16

1.3

1.4

209.12

217.58

pmol/l

0.05

162

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

143

1378

1.04

0.16

1.3

65.22

55.57

au/ml

—

(3044290) Cell count panel - Cerebral spinal fluid

477

1.07

0.15

1.1

1.7

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

197

1.12

0.15

1.5

55.12

56.99

ug/l

0.06

197

(3023410) Appearance of Cerebral spinal fluid

255

1.10

0.15

1.2

2.1

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

0.83

0.13

1.3

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

128

0.86

0.13

1.1

1.2

—

(3016879) Cocaine [Presence] in Urine

714

0.95

0.13

1.6

2.1

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

208

0.91

0.10

1.0

1.1

—

(44806420) Estimation of glomerular filtration rate

208

0.91

0.10

2.8

2.4

—

(3025130) Human papilloma virus identified in Specimen

251

1.08

0.10

1.9

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

1.06

0.09

1.0

24.16

43.54

iu/ml

—

(40761995) Spermatozoa Progressive [#/volume] in Semen

1.06

0.09

3.2

29.00

43.87

—

(3014043) Spermatozoa Nonprogressive/Spermatozoa in Semen

1.06

0.09

6.4

6.5

14.20

8.32

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

312

1.06

0.08

1.3

1.2

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

369

0.95

0.08

1.1

0.54

1.37

u/ml

0.87

179

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

372

1.05

0.07

1.1

49.02

20.99

au/ml

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

378

0.95

0.07

1.1

2.75

4.48

u/ml

0.58

214

(3025018) Bordetella pertussis Ab [Titer] in Serum

147

1.09

0.07

1.0

1.2

—

(4198724) Urine methamphetamine measurement

0.85

0.07

2.0

—

(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum

1.12

0.06

1.5

2.9

15.52

111.61

ug/l

—

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

513

1.03

0.06

1.2

1.7

518.40

675.42

e6/l

0.12

403

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

188

1.06

0.05

1.2

1.5

—

(44813793) Dust mix specific IgE antibody measurement

150

0.93

0.04

1.0

1.1

—

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

507

1.03

0.04

1.2

1.7

15.45

37.61

e6/l

0.63

381

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

441

0.97

0.03

1.1

3.25

2.20

u/ml

0.18

245

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

112

1.07

0.03

1.2

1.7

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

1.08

0.02

1.0

2.1

—

1.38

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

274

2727

1.01

0.02

13.7

7.2

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

559

0.98

0.02

1.5

—

(40768793) Breast Pathology biopsy report

501

1.00

0.00

1.4

1.3

—

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

579

1.00

0.00

1.2

1.5

465.60

556.06

mg/l

1.49

556

(3014599) Egg white IgE Ab [Units/volume] in Serum

124

0.97

0.00

1.0

1.1

0.55

1.33

u/ml

—

(1617658) Protocol used for examination of sentinel lymph nodes

162

0.99

0.00

1.0

1.1

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

172

0.99

0.00

6.6

5.3

46.12

51.26

u/ml

—

(3033306) Mononuclear cells/Leukocytes in Cerebral spinal fluid

103

0.97

0.00

1.0

1.2

—

73.50

—

(3015076) Soybean IgE Ab [Units/volume] in Serum

107

1.03

0.00

1.0

0.16

3.16

u/ml

—

(40762887) Creatinine [Moles/volume] in Blood

0.00

0.0

1.6

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

0.95

0.00

1.2

—

(3033093) Yersinia sp IgM Ab [Titer] in Serum

0.00

-0.00

0.0

2.0

—

(3013762) Body weight Measured

0.00

-0.00

0.0

1.5

—

(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination

0.00

-0.00

0.0

1.0

—

(3009461) 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine

0.00

-0.00

0.0

1.2

—

32.40

—

(40765089) Chromosome analysis panel - Blood by G-banded

0.97

-0.00

1.0

—

(3020356) Listeria sp identified in Specimen by Organism specific culture

0.00

-0.00

0.0

1.0

—

(42870560) Thyrotropin [Units/volume] in Cord blood

0.90

-0.00

1.0

12.57

8.94

mu/l

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

0.90

-0.00

1.0

1.1

—

(3009224) EGFR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

0.00

-0.00

0.0

1.0

—

(3041806) Other cells [#/volume] in Blood by Manual count

0.91

-0.00

2.0

1.5

0.56

0.47

e9/l

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

0.92

-0.00

1.3

1.4

—

(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

0.01

—

(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum

0.00

-0.00

0.0

1.0

—

(3041184) Isoniazid [Presence] in Urine

0.00

-0.00

0.0

1.9

—

(3007463) Buprenorphine [Presence] in Urine

0.00

-0.00

0.0

7.6

—

(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum

0.00

-0.00

0.0

2.0

—

(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination

0.00

-0.00

0.0

1.0

—

(3014591) Smooth Alder IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

7.25

—

(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum

0.00

-0.00

0.0

2.0

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

0.91

-0.00

1.0

1.1

—

Mortality – FinRegistry

↥

Association

Association between endpoint K11_CHOLANGI and mortality.

Females

Parameter	HR [95% CI]	p-value
K11_CHOLANGI	2.458 [2.14, 2.83]	< 0.001
Birth year	0.992 [0.98, 1.0]	0.054

During the follow-up period (1.1.1998 — 31.12.2019), 2720 out of 6016 females with K11_CHOLANGI died.

Males

Parameter	HR [95% CI]	p-value
K11_CHOLANGI	2.52 [2.17, 2.93]	< 0.001
Birth year	0.987 [0.98, 1.0]	0.009

During the follow-up period (1.1.1998 — 31.12.2019), 2735 out of 5897 males with K11_CHOLANGI died.

Mortality risk

Mortality risk for people of age

years, who have K11_CHOLANGI.

N-year risk	Females	Males
1	0.165%	0.495%
5	1.088%	2.92%
10	3.025%	7.448%
15	5.777%	13.209%
20	9.879%	21.994%

Relationships between endpoints

↥

Index endpoint: K11_CHOLANGI – Cholangitis (primary sclerosing, PSC)

GWS hits: -

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Cholangitis (primary sclerosing, PSC)

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints